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ABSTRACT 
Lyme disease is a tick-borne illness caused by the spirochete Borrelia burgdorferi (Bb). It 
is believed that the robust inflammatory response induced by the host’s innate immune 
system is responsible for the clinical manifestations associated with Bb infection. The 
macrophage plays a central role in the immune response to many bacterial infections and 
is thought to play a central role in activation of the innate immune response to Bb. 
Previous studies have shown that following phagocytosis of spirochetes by macrophages, 
phagosome maturation results in degradation of Bb and liberation of bacterial lipoproteins 
and nucleic acids, which are recognized by TLR2 and TLR8, respectively, and elicit 
MyD88-mediated phagosome signaling cascades. Bone marrow-derived macrophages 
(BMDMs) from MyD88-/- mice show significantly reduced spirochete uptake and 
inflammatory cytokine production when incubated with Bb ex vivo. Paradoxically, 
additional studies revealed that Bb-infected MyD88-/- mice exhibit inflammation in joint 
and heart tissues. To determine the contribution of MyD88 to macrophage-mediated 
spirochete clearance, we compared wildtype (WT) and MyD88-/- mice using a murine 
model of Lyme disease.  MyD88-/- mice showed increased Bb burdens in hearts 28 days  
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post infection, while H&E staining and immunohistochemistry showed significantly 
increased inflammation and greater macrophage infiltrate in the hearts of MyD88-/- mice. 
This suggests that Bb triggers MyD88-independent inflammatory pathways in 
macrophages to facilitate cell recruitment to tissues. Upon stimulation with Bb ex vivo, 
WT and MyD88-/- BMDMs exhibit significant differences in bacteria uptake, suggesting 
that MyD88 signaling mediates cytoskeleton remodeling and the formation of membrane 
protrusions to enhance bacteria phagocytosis. A comprehensive transcriptome 
comparison in Bb-infected WT and MyD88-/- BMDMs identified a large cohort of MyD88-
dependent genes that are differentially expressed in response to Bb, including genes 
involved in actin and cytoskeleton organization (Daam1, Fmnl1). We also identified a 
cohort of differentially-expressed MyD88-independent chemokines (Cxcl2, Ccl9) known 
to recruit macrophages. We identified master regulators and generated networks which 
model potential signaling pathways that mediate both phagocytosis and the inflammatory 
response. These data provide strong evidence that MyD88-dependent and -independent 
phagosomal signaling cascades in macrophages play significant roles in the ability of 
these cells to phagocytose Bb and mediate infection. 
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CHAPTER 1: INTRODUCTION 
 
LYME DISEASE PREVALENCE AND CLINICAL MANIFESTATIONS 
Lyme disease (LD) is the most common vector-borne illness in the United States (US). In 
2017 there were 29,513 confirmed cases and 13,230 probable cases reported (CDC 
2016). LD is most prevalent in the northeastern and north Midwestern regions of the US. 
Clinical manifestations range along a spectrum in severity and presentation and vary from 
patient to patient (Figure 1) (CDC 2016). Classic manifestations of LD include 
presentation of the characteristic bullseye rash know as erythema migrans, fever, aches, 
fatigue and other flu-like symptoms. Approximately 30% of patients develop arthritis, while 
smaller percentages of patients develop other severe manifestations including carditis 
(1%), meningitis (2%) and facial palsy (9%) (CDC 2016). Fatal myocarditis is a rare event, 
with only nine cases being reported between 1985 and 2018 (CDC 2016, Muehlenbachs, 
Bollweg et al. 2016).  Despite receiving proper antibiotic treatment, a subset of LD patients 
develops what is termed Post Treatment Lyme Disease Syndrome (PTLDS) (CDC 2016). 
This syndrome develops in approximately 20% of LD cases and does not correlate with 
antibiotic treatment (Adrion, Aucott et al. 2015). PTLDS is indicated by a variety of 
symptoms that are not specific to Lyme disease, such as muscle aches and chronic 
fatigue (CDC 2016).  Another subset of patients develop what is termed antibiotic-
refractory Lyme arthritis. This presents in patients as persistent inflammatory arthritis 
even following antibiotic treatment for Lyme disease, and is potentially due to excessive 
inflammation or immune dysregulation (Steere and Arvikar 2015). Because of the variety 
of clinical manifestations seen in patients, it is widely accepted that the individual immune 
 2 
response to infection is what drives human disease presentation (Bockenstedt 2010, 
Radolf, Caimano et al. 2012). 
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Figure 1: Spectrum of Clinical Manifestions in Lyme Disease. Clinical severity scale 
is plotted according to percentage of exposed individuals. 
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ETIOLOGIC AGENT OF LYME DISEASE 
LD is caused by infection with the spirochetal bacterium Borrelia burgdorferi (Bb). There 
are at least 18 genospecies of Borrelia burgdorferi sensu lato, 3 of which cause most 
human infections (Mead 2015). In North America Borrelia burgdorferi sensu stricto cause 
Lyme disease, which is often distinguished by development of arthritis. The other two 
Borrelia strains that cause most disease in humans are Borrelia garinii and Borrelia 
afezelii, which are more prevalent in Europe (Radolf, Caimano et al. 2012, Steere, Strle 
et al. 2016). Borrelia garinii is distinguished more by presentation of neuroborreliosis and 
Borrelia afezelii is distinguished more by presentation with dermatologic conditions 
(Steere, Strle et al. 2016). 
 
 
MOLECULAR ARCHITECTURE OF BB 
There are multiple components of spirochetes that contribute to their recognition by innate 
immune cells. Bb, an extracellular pathogen, has a unique helical wave morphology with 
unique membrane and metabolic characteristics that differ from both gram-negative and 
gram-positive bacteria (Radolf, Goldberg et al. 1995). Bb does not contain coding material 
for lipopolysaccharide (LPS) and thus does not engage TLR4 (Norgard, Arndt et al. 1996, 
Fraser, Casjens et al. 1997). It also does not contain coding material for any toxins that 
may contribute to pathogenesis, The Bb spirochete forms a helical wave that contains 
both inner and outer membranes. In the periplasmic space between the outer and inner 
membranes there is a peptidoglycan layer and a flagellum that wraps around the cell 
between the outer membrane and the peptidoglycan layer. The flagella are anchored to 
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motors at either end of the spirochete that are controlled by chemotaxis proteins, which 
control direction of cell movement. The inner membrane of Bb contains inner membrane 
lipoproteins, sugar transport systems and ABC transporters. Finally, there are export 
systems that span the inner membrane, the periplasmic space, and the outer membrane. 
The genome of Bb consists of a linear chromosome, 12 linear plasmids, and 9 circular 
plasmids. (Fraser, Casjens et al. 1997). The outer membrane is abundant in a variety of 
lipoproteins. These include outer surface proteins (Osps), decorin-binding proteins 
(Dbps), and complement regulator-acquiring surface proteins (CRASPs) (Kenedy, 
Lenhart et al. 2012). Bb also has porins, which are -barrel proteins that span the outer 
membrane.  
 
OUTER SURFACE PROTEINS: 
OspA/B: OspA and OspB contribute to Bb persistence in ticks. Both lipoproteins are 
expressed when Bb colonizes the tick midgut and are downregulated when the tick begins 
to feed (Pal, de Silva et al. 2000, Schwan and Piesman 2000). OspA binds to the tick 
receptor for OspA (TROSPA) (Pal, Li et al. 2004). Bb mutants deficient in OspA fail to 
survive in the tick midgut (Yang, Pal et al. 2004).  
 
OspC: Expression of OspC is induced within 36 hours of tick feeding and is essential for 
transmission into the mammalian host but is not required for dissemination within the host 
(Schwan 2003, Tilly, Krum et al. 2006).  
 
COMPLEMENT REGULATOR-ACQUIRING SURFACE PROTEINS: 
 6 
CRASPs are Bb lipoproteins on the outer membrane that bind host complement proteins 
in the serum. Bb CRASP proteins include the OspE-related proteins CspA and CspZ 
(Kraiczy, Hellwage et al. 2004, Hartmann, Corvey et al. 2006). These proteins bind Factor 
H and Factor H-like protein-1 (FH and FH-1 respectively) (Hellwage, Meri et al. 2001), 
which are negative regulators of complement. Binding of the proteins on the Bb 
membrane helps the spirochete evade host complement.  
 
 
TRANSMISSION AND LIFE CYCLE OF BB 
Transmission of Bb in North America is through the black-legged deer tick, Ixodes 
scapularis. Humans are considered “dead-end” hosts or incidental hosts because they 
are not natural reservoirs for Bb (Radolf, Caimano et al. 2012). The most common 
mammalian reservoir is the white-footed mouse Peromyscus leucopus. Bb maintains a 
natural enzootic cycle between a tick vector and mammalian reservoir, typically small 
rodents. Naïve larvae become infected when they feed on an infected mammalian host. 
After feeding, the infected larvae molt into nymphs, which then feed on a second 
mammalian host. If this mammalian host is uninfected the infected nymph will transmit Bb 
into the bloodstream via the tick salivary stream. After feeding nymphs will molt into adult 
ticks and females will feed on larger mammalian hosts, which are typically white-tailed 
deer. Adult males do not feed. In addition to feeding, adult ticks breed on white-tailed 
deer. However, deer are non-competent hosts for Bb and do not become infected or 
transmit the spirochetes (Kurtenbach, Hanincova et al. 2006).  
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DISSEMINATION OF BB IN THE MAMMALIAN HOST 
Despite secretion of salivary proteins to inhibit chemotaxis, immune cells are actively 
recruited to the bite site. Blister fluid analysis of EM lesions shows recruitment of dendritic 
cells, macrophages, lymphocytes and neutrophils. Recruitment of these cells results in 
cytokine and chemokine production as part of the inflammatory response. However, Bb 
is still able to disseminate via the hematogenous route in the mammalian host, but does 
not reach high levels in the blood (Wormser 2006). Instead, Bb first travels to target 
tissues by traversing the extracellular matrix or crossing tissue barriers. Target tissues for 
Bb dissemination that can result in severe clinical manifestations include heart, joint and 
brain (Steere and Glickstein 2004). Interactions with the host vasculature through 
fibronectin and various fibronectin-binding proteins expressed on Bb (such as Bbk32) 
contribute to the spirochete’s ability to cross the extracellular matrix (Hyde, Weening et 
al. 2011). As an additional measure to cross the extracellular matrix, Bb also produces a 
bacterial protease (BbHtrA) which can cleave aggrecan, fibronectin and decorin (Russell, 
Delorey et al. 2013). Cleavage of these proteins degrades the extracellular matrix to 
promote invasion of the spirochete. Bb also expresses decorin-binding proteins (ie DbpA) 
which also contribute to its interactions with the host vasculature and contribute to 
dissemination (Guo, Brown et al. 1998). Binding to decorin plays a critical role in 
colonization, since decorin-defcient mice are resistant to infection and Bb that do not 
express DbpA fail to colonize target mouse tissues after inoculation (Fortune, Lin et al. 
2014). Once Bb has disseminated through the human host it seeks to invade target 
tissues through interactions with endothelial cells. Proteins expressed on the outer 
membrane of Bb show affinity to integrins expressed on host endothelial cells. The most 
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well-defined interaction is that of Bb protein P66 with B1 and B3 integrins (Skare, 
Mirzabekov et al. 1997, Coburn, Magoun et al. 1998). P66 is not expressed in Bb during 
tick colonization and Bb strains with mutant P66 can infect mammalian hosts but are 
unable to survive longer than 48 hours, even in the absence of inflammatory cells (Curtis, 
Hahn et al. 2018). This suggests an important role for P66 in transmission (Ristow, Miller 
et al. 2012). 
 
IMMUNE CELLS IN RESPONSE TO BB INFECTION  
Adapted from (Cervantes, Hawley et al. 2014) 
Unlike the reservoir hosts, humans mount significantly inflammatory responses to the 
spirochete that result in development of symptoms. Human infection with Bb induces both 
innate and adaptive immune responses, and it is believed that the innate immune 
response to the spirochete plays an important role in the severity of clinical manifestations 
during early LD (Bockenstedt 2010, Radolf, Caimano et al. 2012). A great amount of 
research has been done on the involvement of different parts of the innate and adaptive 
immune responses relating to infection with Bb. In the innate response, monocytes, 
macrophages, dendritic cells, Natural Killer cells (NK cells), NK-T cells and neutrophils 
have all been demonstrated to play an active role in the host response (Bockenstedt 2010, 
Radolf, Caimano et al. 2012, Cervantes, Hawley et al. 2014, Steere, Strle et al. 2016). T-
cells and B-cells play a critical role in the adaptive immune response. Excluding the 
macrophage, the specific roles of each cell type have been described in more detail 
below. Because of the significance of macrophages in these studies, they will be reviewed 
in greater detail in the next section. 
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Figure 2: Innate signaling cascade in response to Bb Phagocytosis. Monocytes 
produce IL-12 to activate Th1 cells and IL6 and IL-1β to activate Th17 cells. Monocytes 
differentiate into macrophages when stimulated with IFN-γ (produced by Th1 cells) and 
M-CSF (produced by Th17 cells) and differentiate into dendritic cells when stimulated 
with IL-4 and IFN-γ. M0 macrophages produce IL-18 to activate Th1 cells and IL-6 and 
IL-1β to activate Th17 cells, as well as several PMN recruitment chemokines. They also 
differentiate into M1 macrophages when stimulated with GM-CSF and IFN-γ. Dendritic 
cells produce IL-6, IL-1β, and TGF-β to activate Th17 cells. Th17 cells produce IL-17, 
which is a strong PMN attractant. Part of images from Motifolio drawing toolkit 
(www.motifolio.com) were utilized in the figure preparation.  
 
Figure adapted from (Cervantes, Hawley et al. 2014) 
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Monocytes: Monocytes contribute to the innate immune response through pro-
inflammatory cytokine production after phagocytosis. These cytokines include IL-6, TNF-
alpha, and IL-12. The increased IL-6 production helps induce Th17 helper cell 
differentiation which leads to neutrophil recruitment through IL-17 production. Production 
of TNF helps facilitate recruitment of leukocytes and neutrophils by increasing vascular 
permeability at sites of infection. Finally, production of IL-12 drives Th1 differentiation, 
which results in increased IFN production that helps activate macrophages.  
 
Dendritic Cells: Dendritic cells are very early responders to sites of Bb infection. 
Characterization of these cells after phagocytosis of Bb showed increased expression of 
CD40, CD80, CD83, CD86 and HLA-DR. Like monocytes, dendritic cells produce IL-6, 
TNF and IL-12 in response to Bb. They also produce TGF, which helps Th17 
differentiation, and IL-8, a neutrophil chemoattractant. To help regulate the inflammatory 
response, dendritic cells produce IL-10 which downregulates proinflammatory mediators. 
Finally, dendritic cells play a critical role in Bb antigen presentation to T-cells, which 
induces the adaptive immune response. 
 
NK Cells and NKT Cells: While very little work has been published studying the effect of 
Bb on NK cells, there have been several studies characterizing the role of NKT cells in 
Bb infection. NKT cells have an important role in Bb clearance, since studies show that 
depleting NKT cells in mice results in higher bacterial burdens. NKT cells produce IFN 
in response to Bb, which aids in macrophage activation. 
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Neutrophils: Neutrophils are not only early responders to site of Bb infection, but also 
play an important role in development of Lyme arthritis. This has been shown in both 
mice, where they have been shown to play a significant role in arthritis development and 
severity, and in humans, where they are the primary cell type present in synovial fluid. In 
response to Bb, neutrophils make several inflammatory cytokines and chemokines that 
aid in both macrophage and T-cell activation.  
 
T cells: T cells are important sources of IFN and are recruited to erythema migrans 
lesions in humans (Salazar, Pope et al. 2003). While they are not required for 
development of arthritis or carditis, Th1 cells are the predominant infiltrate in patients with 
Lyme arthritis and can exacerbate the severity of arthritis in the absence of B cells(Steere 
and Glickstein 2004). The regulation and function of regulatory cells is also disrupted in 
patients with Lyme arthritis (Vudattu, Strle et al. 2013). They also play a role in controlling 
Bb infection, since mice lacking T cells show higher spirochete burdens. CD4+ and CD8+ 
T cells can be activated by TLR signaling in response to Bb ligands, in addition to being 
activated by antigen presentation (Whiteside, Snook et al. 2018). 
 
B cells: B cells can be activated by Bb both dependently and independently of helper 
CD4+ T cells (Hastey, Ochoa et al. 2014). Bb has been shown to migrate to lymph nodes 
to activate B cells via costimulation of their receptors (Tunev, Hastey et al. 2011). In 
addition, B-cells have been shown to make highly specific antibodies to Bb in both mice 
and humans, producing both IgM and IgG. However, the process of affinity maturation is 
not effective, and the humoral response is short-lived (Elsner, Hastey et al. 2015). This 
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antibody production plays an important role in recognizing bacteria peptides leftover from 
degradation and may contribute to arthritis severity.  
 
Macrophages: Macrophages are highly phagocytic professional antigen presenting 
innate immune cells. They contain the machinery necessary to bind, engulf and degrade 
Bb. The macrophage is a principle component of the innate immune response and has 
been observed at sites of Bb infection (Salazar, Pope et al. 2003, Shin, Strle et al. 2010, 
Lasky, Olson et al. 2015). In humans, macrophages are recruited to sites of Bb infection 
in early stages and have been identified in EM lesions of patients with acute LD. They 
produce large amounts of chemokines at EM lesions in response to Bb. Macrophages 
also play a prominent role in the pathogenesis of murine Lyme carditis, and their 
recruitment to heart tissue is important in bacterial clearance (Montgomery, Booth et al. 
2007). However, the mechanisms behind how these signaling cascades allow 
macrophages to initiate effective internalization and mediate inflammation are not well 
characterized.  
 
INFLAMMATORY RESPONSES TRIGGERED BY BB 
There are multiple Bb ligands that can trigger an innate immune response in the human 
host. Lipoproteins isolated from Bb were shown to be activators of both human and 
murine immune cells, even before the discovery of TLRs (Brandt, Riley et al. 1990, Radolf, 
Norgard et al. 1991). More importantly, the response elicited by macrophages stimulated 
with Bb lipoproteins or LPS (absent on the Bb outer membrane) was very similar (Radolf, 
Arndt et al. 1995, Radolf, Goldberg et al. 1995, Norgard, Arndt et al. 1996). Bb lipoproteins 
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contain triacyl peptides that can be recognized by TLR2/1 heterodimers (Hirschfeld, 
Kirschning et al. 1999, Wooten, Ma et al. 2002). Triacylation of lipoproteins is required for 
them to be localized to the Bb outer membrane and occurs in the spirochete through 
addition of first a diacylglyceride moiety onto a cysteine residue in the N-terminal region. 
This embeds the lipoprotein in the inner membrane and is followed by addition of a third 
fatty acid chain which facilitates transportation to the outer membrane. TLR2 recognizes 
the diacylglyceride moiety while TLR1 contains a hydrophobic pocket (absent in TLR6) 
that can recognize the additional fatty acid chain (Schenk, Belisle et al. 2009). The 
response is also enhanced by interaction of CD14 with the Bb PAMP-TLR2 complex. 
Early experiments investigating the role of CD14 on immune cell activation suggested 
that surface exposure of lipoproteins on the Bb outer membrane is important in initiating 
an immune response (Sellati, Bouis et al. 1999). However, the absence of CD14 results 
in more severe inflammatory responses both in vitro using human and murine cells and 
in vivo using CD14-/- mice (Benhnia, Wroblewski et al. 2005).  
Following the discovery of Bb lipoprotein recognition by TLR2, it was discovered that in 
human cells a more significant immune response is elicited against live intact Bb rather 
than lysed or heat-killed spirochetes (Moore, Cruz et al. 2007). This is due to the location 
of the lipoprotein lipid moiety which serves as the TLR2 PAMP; it is embedded in the Bb 
outer membrane and tethers it to the surface. As a result, minimal recognition occurs at 
the cell surface (Moore, Cruz et al. 2007, Shin, Isberg et al. 2008, Salazar, Duhnam-Ems 
et al. 2009, Schenk, Belisle et al. 2009). Instead, principal recognition of Bb TLR2 ligands 
occurs within macrophage endosomal structures when the spirochete is phagocytosed, 
and its fragile outer membrane is compromised (Moore, Cruz et al. 2007, Shin, Isberg et 
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al. 2008). Thus, while some engagement of TLR2 is at the cell surface, the majority of Bb 
lipoprotein recognition occurs in the phagosome by endosomal TLR2 (Salazar, Duhnam-
Ems et al. 2009, Cervantes, Dunham-Ems et al. 2011).  In the absence of TLR2, murine 
macrophages do not show any defect in uptake of Bb (Salazar, Duhnam-Ems et al. 2009). 
However, mice lacking TLR2 show increased spirochete burdens in ankle, ear and heart 
tissue two and four weeks post Bb infection (Wooten, Ma et al. 2002).  
 
In addition to Bb lipoprotein recognition by TLR2, other bacterial ligands are released into 
the phagosome for recognition by endosomal TLRs. As the spirochete is degraded, 
nucleic acids are released into the phagosomal compartment. These include Bb DNA and 
Bb RNA. Bb RNA is recognized by TLR7 in mouse cells and TLR8 in human cells (Petzke, 
Brooks et al. 2009, Cervantes, La Vake et al. 2013). Bb DNA is recognized by TLR9 (Shin, 
Isberg et al. 2008). Engagement of these TLRs by their Bb ligands results in production 
of type I interferons.   
 
TLR2, TLR7, TLR8 and TLR9 appear to make the most significant contribution to Bb 
recognition by immune cells. Other endosomal TLRs appear to make a minimal, if any 
impact on initiating an immune response. The lack of LPS in Bb prevents recognition by 
TLR4. Pre-stimulation of macrophages with TLR3 ligands has no significant impact on 
cytokine response (Shin, Miller et al. 2009), indicating that TLR3 engagement and 
signaling do not appear to significantly contribute to the Bb inflammatory response. While 
Bb does have flagella located in the periplasmic space that can be recognized by TLR5, 
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cytokine production in macrophages pretreated with siRNA against TLR5 show no defect 
in phagocytosis or cytokine production (Shin, Isberg et al. 2008).  
 
When taken together, the work described above defines a concept known as 
“phagosomal signaling”, which refers to the signaling cascades that are emitted from 
phagosomes due to recognition of ligands that are only accessible within the acidic 
environment of the phagosome. Phagosomal signaling emphasizes that because of the 
unique bacterial structure it is necessary for Bb to be taken up and degraded for significant 
recognition by the host immune system (Cervantes, Hawley et al. 2014) and is critical in 
the innate immune response to Bb because borrelial PAMPs are not exposed for 
recognition at the surface. To compensate for this, TLRs are recruited to phagosomes 
containing Bb. The TLRs that recognize Bb ligands all utilize the adaptor protein MyD88, 
making it a critical component in triggering inflammatory signaling in response to the 
spirochete.  
 
THE ADAPTOR PROTEIN MYD88 
MyD88 is the principle adaptor protein for TLR signaling. Once the TLRs bind to their 
ligand and heterodimerize, MyD88 binds to the cytoplasmic domain of the TLR and 
creates a scaffold for IRAK-1 and IRAK-4 to bind. This complex recruits TRAF-6, an E3 
ubiquitin ligase that adds polyubiquitin chains in collaboration with TRICA-1, an E2 
ubiquitin ligase. The addition of polyubiquitin chains onto both TRAF-6 and NEMO allow 
recruitment and activation of TAK1. Once activated, TAK1 phosphorylates IB on NFB 
and targets it for degradation. This activates NFB and allows it to translocate into the 
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nucleus to induce proinflammatory cytokine production. Signaling cascades initiated by 
engagement of these TLRs are mediated by binding the adaptor protein MyD88. The 
TLRs involved in recognizing Bb utilize MyD88 to trigger phagosomal signaling cascades, 
making this adaptor protein a crucial element in mediating the inflammatory response to 
Bb. Nevertheless, the key host components involved downstream of these MyD88-
mediated phagosome signals and their effects have not been well studied in the context 
of Bb infection. 
MyD88 has been shown to be implicated in multiple processes relating to bacterial 
recognition and clearance. Previous studies have shown that MyD88 has no effect on 
bacterial binding (Blander and Medzhitov 2004). Murine macrophages lacking MyD88 
show markedly diminished uptake of several bacterial species, including Bb (Takeuchi, 
Hoshino et al. 2000, Edelson and Unanue 2002, Blander 2007, Shin, Isberg et al. 2008, 
Ip, Sokolovska et al. 2010, Shen, Kawamura et al. 2010). Links between MyD88 signaling 
and proteins associated with phagocytosis have been studied (reviewed in the following 
section). The absence of MyD88 also results in a defect in phagosome maturation and 
acidification. In the absence of MyD88, degradation of multiple bacteria strains is also 
impaired due to inefficient acidification of phagosomes (Blander and Medzhitov 2004). 
However, in the context of Bb infection, lysosome maturation markers are recruited to Bb-
containing phagosomes in macrophages lacking MyD88 (Shin, Isberg et al. 2008). The 
degree of phagosome maturation and acidification required to expose Bb ligands from 
the bacteria cell envelope for recognition is not known. Murine macrophages lacking 
MyD88 also show diminished production of NFκB-triggered pro-inflammatory cytokines, 
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such as TNF and IL-6, when stimulated with different bacterial species, including Bb 
(Edelson and Unanue 2002, Shin, Isberg et al. 2008).  
Paradoxically, mice lacking MyD88 show comparable levels of inflammation to WT mice 
in heart and joint tissue when infected with Bb (Bolz, Sundsbak et al. 2004, Liu, 
Montgomery et al. 2004, Behera, Hildebrand et al. 2006). This Bb-induced inflammation 
in MyD88-/- mice in joint tissues consists of a cell infiltrate that is more neutrophilic 
compared to WT mice (Bolz, Sundsbak et al. 2004). Comparable levels of inflammation 
in Bb-infected WT and MyD88-/- mice also suggests that the macrophage may help drive 
additional MyD88-independent inflammatory responses (Behera, Hildebrand et al. 2006). 
Bb-infected MyD88-/- mice also show significantly higher bacterial burdens in joint and 
bladder tissues (Bolz, Sundsbak et al. 2004, Liu, Montgomery et al. 2004, Behera, 
Hildebrand et al. 2006), which is not surprising given that the absence of MyD88 in 
macrophages also results in reduced spirochete uptake (Shin, Isberg et al. 2008). 
Increased pathogen burdens is a common phenotype in MyD88-/- when they are infected 
with multiple bacteria species (Ribes, Regen et al. 2013). 
 
PHAGOCYTOSIS OF BB 
Phagocytosis is a highly dynamic process that involves multiple cell processes. The 
events leading to phagosome formation can be summarized in four discrete steps: 
dynamic probing, particle binding that induces receptor clustering, phagocytic cup 
formation, and phagosome sealing (Levin, Grinstein et al. 2016, Niedergang and 
Grinstein 2018). Probing of the cell membrane results in surface receptor clustering when 
a phagocytic target is recognized. The receptor cluster allows for recruitment of kinases 
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such as Syk, which phosphorylates phagocytic receptors for activation, and PI3K, which 
converts PtdIns(4,5)P2 (PIP2) on the plasma membrane to PtdIns (3,4,5)P3 (PIP3). High 
levels of PIP3 in the plasma membrane initiate recruitment of guanine exchange factors 
(GEFs) and Rho-GTPases such as Rac1 and Cdc42. These proteins, through the WAVE 
or WASP protein complex, recruit and activate Arp2/3 for actin polymerization (Takenawa 
and Suetsugu 2007, Devreotes and Horwitz 2015). This results in two membrane 
protrusions that form a phagocytic cup around the target for uptake into the cell.  
 
There are three different forms of phagocytosis that have been studied with Bb; opsonin-
mediated phagocytosis, conventional phagocytosis, and coiling phagocytosis (Figure 3) 
(Cervantes, Hawley et al. 2014). Opsonin-mediated phagocytosis is mediated by the 
binding of opsonin antibodies to Bb and then triggering phagocytosis through ligation of 
Fc receptors expressed on the surface of professional immune phagocytes. Opsonic- 
mediated phagocytosis can occur with Bb and has been shown to play a role in pathogen 
burden and arthritis severity (Belperron, Liu et al. 2014), but professional immune 
phagocytes do not require opsonic antibodies to efficiently phagocytose Bb (Hawley, Cruz 
et al. 2017). Conventional phagocytosis requires the presence of a surface receptor that 
recognizes Bb and triggers membrane ruffling so that the spirochete is enveloped and 
sinks into the cell. inding of Bb to macrophages is mediated by surface integrins. Several 
surface integrins have been identified as receptors for Bb, including complement receptor 
3 (CR3) and 31 (Behera, Hildebrand et al. 2006, Hawley, Martin-Ruiz et al. 2013). 
Once attached, the mechanism by which Bb is phagocytosed is complex and can occur 
by either a sinking or coiling mechanism (Naj, Hoffmann et al. 2013, Cervantes, Hawley 
 19 
et al. 2014). Both mechanisms require actin cytoskeleton rearrangement to internalize Bb 
into the endosome, where degradation takes place (Naj and Linder 2015). However, the 
mechanisms behind how these signaling cascades allow macrophages to initiate effective 
internalization and mediate inflammation are not well characterized. Coiling phagocytosis 
requires cell remodeling in order to occur. The cell protrudes a pseudopod out of the 
plasma membrane that can bend around the bacteria in a hook-like fashion. These 
pseudopod protrusions are the result of F-actin polymerization that is regulated by 
GTPases, Cdc42, Rac1. The WASP and Arp2/3 complexes are also involved. In the 
context of Bb phagocytosis, the formin proteins Daam1, Fmnl1 and mDia1 have been 
shown to play a role in the branching of actin filaments (Williams, Weiner et al. 2018).  
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Figure 2: Phagocytosis of Borrelia burgdorferi. (A) Opsonic-mediated phagocytosis—
complement factors, such as C3b and iC3b, bound to the surface of Bb can interact with 
complement receptors and mediate phagocytosis. Additionally, the immune cells Fc-
receptors have the ability to bind to the opsonic antibodies that coat Bb and internalize 
the pathogen. (B) Conventional phagocytosis—the direct interaction of surface receptors 
with Bb, such as integrins and C-type lectins, allows for tether of the spirochete to the cell 
surface. Various PRRs induced signal cascade initiates formation of the phagocytic cup 
and spirochete engulfment. (C) Coiling phagocytosis—the preferred mechanism of 
spirochete internalization in which the phagocytic cell uses filopodial protrusions that 
capture Bb. The filopodial enwrap the spirochete and convert into coiling pseudopods. 
During this dynamic process FMNL1, mDai1 Arp2/3 complex, and WASP are involved in 
actin rearrangement of the cell, which then facilitates subsequent phagocytosis of Bb. 
Following internalization of Bb, the spirochete is degraded within the phagosome thus 
exposing additional PAMPs to PRR with in the phagosome. The phagosomal signals 
initiated by Bb generates a robust inflammatory response, including the induction of pro-
inflammatory genes and Type I IFNs.  
 
Figure adapted from (Cervantes, Hawley et al. 2014) 
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MURINE MODELS OF LD 
Bb infection has been modeled in 5 different strains of laboratory mice; C3H/He, SWR, 
C57BL/6, SJL and BALB/c (Barthold, Beck et al. 1990, Barthold, Persing et al. 1991, 
Armstrong, Barthold et al. 1992, de Souza, Smith et al. 1993). Currently, the most 
common mouse strains studied are C57BL/6 and C3H/He, with genetic modifications 
based off these strains. In humans, carditis and arthritis are considered severe clinical 
manifestations that can be modeled in murine infection and are most commonly evaluated 
in mice. Of the strains evaluated, C3H/He mice display the most severe arthritis (Barthold, 
Persing et al. 1991). Bb disseminates to multiple tissues when inoculated in mice, 
including bladder, ear, skin, heart, joint, lymph node and spleen. Despite having high 
burdens during the initial stages of infection, C57BL/6 mice remain relatively 
asymptomatic with no joint swelling or weight loss. C3H/He mice development severe 
arthritis as indicated by ankle swelling, but still manage to reduce spirochete loads in 
tissues 3 weeks post infection. 
 
SUMMARY OF THESIS CONTENT 
The primary goal of the work presented in this dissertation is to understand how MyD88 
mediates macrophage recognition and clearance of Bb both in vivo and ex vivo. Through 
murine infection, macrophage stimulation in culture, and computational analysis we have 
gained mechanistic insights into MyD88-dependent and -independent effects on 
inflammation and Bb uptake. 
In Chapter 3 we define the role of MyD88 on Bb burdens, immune cell infiltrate, activated 
macrophage infiltrate, and inflammatory transcript response in target tissues. We identify 
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several chemokines that are produced in the absence of MyD88 and may contribute to 
cell recruitment during Bb infection. Here we show using a murine model of LD that 
MyD88 plays a role in inflammation severity in heart, but not joint tissue and is not required 
for immune cell recruitment. However, the presence of MyD88 is associated with Bb 
clearance from multiple tissues in the mouse, including heart and tibiotarsal joint. We also 
show that there are tissue-specific chemokine responses, resulting in different types of 
cell infiltrate and inflammation severity in the absence of MyD88. Taken together, our 
findings underscore the importance of the macrophage in Bb recognition and clearance 
and identify key MyD88-dependent components that play a significant role in mediating 
these processes. 
In Chapter 4 we examine the effect of MyD88 on macrophage binding and uptake. We 
also characterize the colocalization of key receptors with Bb-containing phagosomes and 
confirm that MyD88 is not necessary for sufficient degradation of Bb. Finally, we show 
that production of MyD88-dependent chemokines is phagocytosis-dependent. Using an 
ex vivo murine macrophage system, we show that in the context of Bb stimulation, MyD88 
signaling enhances, but is not required, for bacterial uptake and is not required for 
phagosome maturation. 
In Chapter 5 we perform a comprehensive analysis of RNA sequencing data and identify 
MyD88-dependent genes involved in Bb uptake. We also characterize MyD88-
independent inflammatory pathways through identification of master regulator proteins. 
Using an RNA-sequencing approach, we demonstrate that uptake of Bb by macrophages 
induces robust MyD88-independent inflammatory responses via phagocytosis-dependent 
production of chemokine proteins that can mediate cell recruitment to tissues. Taken 
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together, our findings underscore the importance of the macrophage in Bb recognition 
and clearance and identify key MyD88-dependent components that play a significant role 
in mediating these processes. 
This body of work progresses the field of Bb immunology by proposing mechanisms that 
link MyD88 signaling with enhanced phagocytosis of Bb. It also identifies potential targets 
that can be tested and translated in human cells to better understand what inflammatory 
pathways contribute to Lyme disease severity in humans. 
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CHAPTER 2: MATERIALS AND METHODS 
MICE:  
Female 6-8-week-old C57BL/6J wild-type (WT) and C57BL/6J MyD88-/- (MyD88-/-) mice 
(Adachi, Kawai et al. 1998) used in these studies were obtained from breeding colonies 
maintained in the UConn Health (UCH) Center for Comparative Medicine facility 
according to protocols approved by the UCH Institutional Animal Care and Use 
Committee. Original WT breeding pairs were purchased from The Jackson Laboratory 
(Bar Harbor, Maine). Original MyD88-/- breeding pairs were kindly provided by Dr. Egil 
Lien at the University of Massachusetts with permission from Dr. S. Akira in Osaka, 
Japan. Disruption of the murine MyD88 gene was confirmed through PCR (Adachi, Kawai 
et al. 1998).  WT and MyD88-/- mice were maintained on the antibiotic Sulfatrim 
(sulfomethoxazole [40 mg/mL] + trimethoprim [8 mg/mL]) diluted in water 1:50, which 
have been previously shown to not impact the degree of Bb infection (Liu, Montgomery 
et al. 2004).  
 
BACTERIAL STRAINS:   
Low-passage virulent wild-type strain 297 (Steere, Grodzicki et al. 1984) or a strain 297 
isolate containing a stably-inserted copy of green fluorescent protein (GFP) under the 
control of the constitutively-expressed flaB promoter (Bb914) (Dunham-Ems, Caimano et 
al. 2009) were maintained in Barbour-Stonner-Kelly (BSK)-II media supplemented with 
6% normal rabbit serum (Dunham-Ems, Caimano et al. 2009) and  gentamicin (50 g/l). 
For temperature-shift, cultures were grown at 23C for at least one week prior to being 
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shifted to 37C as previously described(Dunham-Ems, Caimano et al. 2009). Spirochetes 
were counted by dark-field microscopy using a Petroff-Hausser counting chamber 
(Hausser Scientific) and diluted in BSK-II for experimental use. For ex vivo experiments, 
spirochetes were centrifuged at 3300 x g for 20 minutes at 4C and suspended in DMEM 
(Gibco, 15630-080) supplemented with sodium pyruvate (Gibco, 11360-070) and HEPES 
(Gibco, 15630-080). After resuspension the cultures were counted by darkfield and 
diluted accordingly.  
 
MOUSE INOCULATION:  
Sex- and age-matched WT and MyD88-/- mice (6 mice per genotype per experiment) 
were injected intradermally with either 1 x 105 temperature-shifted Bb diluted in BSK-II or 
an equal volume of media alone and then sacrificed 14, 28, or 58 days post-infection. 
Infection was confirmed at 2 weeks post-infection by serology and culturing of ear tissue 
in BSK-II. Cultures were examined weekly for spirochetes by darkfield microscopy for at 
least 4 weeks. Serum was tested against Bb strain 297 whole cell lysates via 
chemiluminescent immunoblot using goat anti-mouse HRP-conjugated IgG (GE NA931) 
as previously described (Dunham-Ems, Caimano et al. 2012).  
 
QUANTITATION OF BB BURDENS IN MOUSE TISSUES:  
Mouse heart, tibiotarsal joint, bladder, skin, and ear tissues were harvested at the time of 
sacrifice. Skin for DNA isolation was taken from the abdomen of the mouse. Tissues were 
digested overnight in 0.1% Collagenase Type I in PBS (Gibco, 17100-017) at 37C, then 
further digested with proteinase K solution (200 mM NaCl, 20 mM Tris-HCl pH 8.0, 50 
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mM EDTA, 1% SDS, 0.2 mg/mL Proteinase K (Machery-Nagel, 740506) in dH2O) 
overnight at 56C. DNA from 200L of digested tissue was isolated using a genomic DNA 
purification kit (Machery-Nagel, 740952) according to manufacturer’s instructions. 
Spirochete burdens were quantitated by qPCR using TaqMan-based assays for Bb flaB 
and murine nidogen (nido) as previously described. The primers and probe used to detect 
flaB were flaB-F (5-CTTTTCTCTGGTGAGGGAGCTC-3’) and flaB-R (5’-
GCTCCTTCCTGTTGAACACCC-3’) and flaB-probe (5’-FAM-
CTTGAACCGGTGCAGCCTGAGCA-3’-BHQ1). The primers and probe used for nidogen 
were nidogen-F (5’-CCCCAGCCACAGAATACCAT-3’), nidogen-R (5’-
AAAGGCGCTACTGAGCCGA-3’), and nidogen-probe (5’-FAM-
CCGGAACCTTCCCACCCAGC-3’-BHQ1). The copy numbers for flaB and nidogen 
genes were calculated by the Bio-Rad software (Version 3.1) based on standard curves 
(107 – 102 copies) generated from cloned versions of the corresponding amplicon as 
previous described. flaB copy numbers were normalized to nidogen. General statistical 
analysis was performed using GraphPad Prism 4.0 (GraphPad Software, San Diego, CA), 
using an unpaired Student t test. For each experiment, both the standard deviation and 
the standard error of the mean were calculated. p values of <0.05 were considered 
significant. 
 
HISTOPATHOLOGY:  
Mouse tibiotarsal joints and hearts were fixed for one week in 10% buffered formalin. 
Joints were decalcified using 8% formic acid for 48 hours after fixation. Tissues were then 
embedded in paraffin and 5 m sections were cut using a microtome and floated on to 
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glass slides using a 40C water bath. Tissues were stained in hematoxylin solution for 90 
seconds and Eosin Y solution for 18 seconds. Joints were scored on a scale of increasing 
severity from 1-3 by a pathologist in a blinded fashion for arthritis severity. Hearts were 
scored on a scale of increasing severity from 1-3 by a pathologist in a blinded fashion 
according to type and volume of cell infiltrate. General statistical analysis was performed 
using GraphPad Prism 4.0 (GraphPad Software, San Diego, CA), using an unpaired 
Student t test. For each experiment, both the standard deviation and the standard error 
of the mean were calculated. p values of <0.05 were considered significant. 
 
RNA ISOLATION FROM MOUSE TISSUES: 
Mouse tibiotarsal joints and hearts were homogenized using an electric homogenizer with 
toothed blades in tissue lysis buffer (Machery-Nagel, 740962) containing beta-
mercaptoethanol (diluted 1:100) (Bio-Rad, 161-0710) and Triton-X-100 (diluted 1:100) 
(Fisher, BP151-100). RNA was isolated from tissue lysates using a Nucleospin RNA Kit 
(Midi column, Machery-Nagel, 740962) according to the manufacturer’s instructions for 
fibrous tissues. RNA was quantified using a Nanodrop spectrometer (Thermo-Fisher). 
cDNA was generated from 2.5 nanograms total RNA using a High-capacity cDNA 
Reverse Transcriptase kit (Applied Biosystems, 4368814) according to manufacturer’s 
instructions. Gene-specific qRT-PCR analyses were performed as previously described 
(Cervantes, La Vake et al. 2013). Expression levels for selected genes (Table S1) were 
normalized to Gapdh (Mm99999915_g1) and the fold changes in gene expression relative 
to the unstimulated or uninfected control were calculated using the 2−ΔΔCt method 
(Schmittgen and Livak 2008). Statistical analysis of the differences in fold changes was 
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performed using GraphPad Prism 4.0 (GraphPad Software, San Diego, CA), using an 
unpaired Student t test. For each experiment, both the standard deviation and the 
standard error of the mean were calculated. p values of <0.05 were considered significant. 
 
BMDM STIMULATION:   
Bone marrow-derived macrophages (BMDMs) were isolated from 6-8-week-old WT and 
MyD88-/- mice as described previously (Salazar, Duhnam-Ems et al. 2009). Single cell 
macrophage suspensions were seeded into either 12-well tissue culture-treated plates at 
a concentration of 106 cells/ml per well or 105 cells/500L per well in 8-chamber cell 
microscopy slides. Slides and plates were then incubated overnight at 37°C/5% CO2 to 
allow cell adherence before experimentation. Cells were incubated for either 1, 4 or 6 
hours at 37°C/5% CO2 with live GFP-Bb at multiplicities of infection (MOIs) of either 10 or 
100. Stimulation media was DMEM supplemented with 1% sodium pyruvate and 1% 
HEPES. For stimulations looking at the effect of Bb uptake, Cytochalasin D (Sigma, 
C8273-1MG) was added to wells at a concentration of 10g/mL and incubated at 37C 
for 1 hour before addition of Bb. At the end of the incubation period, culture supernatants 
were collected and stored at −80°C until cytokine analysis. Cells stimulated in chamber 
slides were processed for confocal microscopy. Cell stimulated in 12-well plates were 
processed for RNA extraction. All culture media and reagents utilized in the stimulation 
experiments were confirmed to be free of LPS contamination (<10 pg/ml) by Limulus 
amoebocyte lysate assay quantification (Cambrex, MA). 
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CONFOCAL MICROSCOPY:   
After stimulation BMDMs were fixed in 2% paraformaldehyde with 0.05% Triton-X-100 
(Fisher, BP151-100) for 10 minutes. Slide wells were then incubated with 5% bovine 
serum albumin (BSA) solution in PBS overnight at 4C to block non-specific antibody 
binding. The next day, cells were stained with different combinations of anti-GFP (Thermo 
Scientific A-21311, 1:100), phalloidin conjugated with Alexa Fluor 647 (Biolegend 424205, 
1:20), anti-MyD88 (Santa Cruz 11356, 1:100), anti-TLR2 (eBioscience 14-9021-82, 
1:100), anti-TLR7 (R&D MAB7156, 1:100) and anti-LAMP-1 (eBioscience 14-1071-82, 
1:100). A secondary antibody was used to detect anti-MyD88, anti-TLR2, and anti-LAMP-
1 (Molecular Probes Alexa Fluor 568, A11036) (1:200). Incubations with primary and 
secondary antibodies were done for 1 hour each at room temperature and slide wells 
were washed following each incubation three times with PBS supplemented with 0.5% 
Tween-20, with a final wash in distilled H2O before mounting. After antibody staining 
slides were mounted using Vectashield mounting medium (Vector H-1000) and imaged 
using a Zeiss 880 confocal microscope. Image processing and analysis were performed 
using ImageJ (NIH, v1.41b). Colocalization values were determined by first analyzing 
profile plots in Image (“Plot Profile”) across ten different phagosomes for each cell 
genotype and then calculating the average difference between the fluorescence intensity 
curves of the markers of interest (i.e., LAMP-1 and Bb). Uptake percentages were 
calculated by imaging 100-200 cells using a confocal microscope and then measuring the 
ratio of cells containing at least one internalized spirochete to the total number of cells 
imaged for each condition, represented as %Bb-positive BMDMs.  
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WESTERN BLOTTING OF BMDM SUPERNATANTS AND LYSATES: 
Protein lysates were generated from BMDM cell culture lysates and supernatants after 
Bb stimulation. In these experiments, adenosine triphosphate (ATP) (Sigma, 3A6419-1G) 
was added to WT BMDMs (already stimulated with Bb) 1 hour prior to harvest for 
generation of lysates. Supernatants were treated with an equal volume of methanol and 
¼ volume of chloroform, vortexed and spun at 16,000 x g for 10 minutes. After removal 
of the upper phase 500L of methanol was added to the intermediate phase which was 
then vortexed and spun at 16,000 x g for 10 minutes. The pellets were then dried at room 
temperature, resuspended in 30 L of 2x Laemmli buffer and incubated in a 37C water 
bath until proteins became soluble. Stimulated BMDMs were lysed using RIPA buffer at -
80C and spun at maximum speed for 10 minutes. Protein pellets were resuspended in 
2x Laemmli buffer. Lysates were boiled at 99C for 10 minutes and run on a 12.5% SDS-
PAGE gel at 140V for 1 hour (5 L per lane, 15 lanes). Protein from the gel was then 
transferred to a nitrocellulose membrane (Bio-Rad 162-0177) at 20V for 20 minutes. 
Membranes were incubated overnight at 4C with primary antibodies for either -actin 
(Sigma A5441, 1:2000), IL-1 (R&D AF401NA, 1:800) or Caspase-1 (Adipogen AG-20B-
0042, 1:1000) diluted in milk block solution. Membranes were then washed 5 times for 5 
minutes each in wash buffer and incubated with goat anti-mouse HRP-conjugated IgG 
(GE NA931) diluted 1:5000 (-actin and Caspase-1) or 1:1000 (IL-1) in milk block for 2 
hours at room temperature. Washes were then repeated as described above and 
membranes were incubated in HyGlo spray chemilunescent substrates (Denville 
Scientific, E2400) for 5 minutes and imaged on a Bio-Rad ChemiDoc MP imaging system. 
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CYTOKINE ANALYSIS:   
The Cytokine Bead Array Mouse Inflammation kit (BD Biosciences 552364) was used 
according to manufacturer’s instructions for simultaneous measurement of IL-6, IL-10, 
MCP-1, IFN, TNFα, and IL-12p70 in supernatants from stimulated BMDMs. General 
statistical analysis was performed using GraphPad Prism 4.0 (GraphPad Software, San 
Diego, CA), using an unpaired Student t test. For each experiment, both the standard 
deviation and the standard error of the mean were calculated. p values of <0.05 were 
considered significant. 
 
IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES BY RNA-SEQUENCING:  
Total RNA was extracted from three biological replicates of WT and MyD88-/- BMDMs, 
either unstimulated or stimulated for 6 hours with Bb at MOI 10:1 or MOI 100:1. RNA was 
isolated using the total RNA isolation kit (Macherey-Nagel) and was used as input for the 
Ovation RNA-seq V1 kit (NuGen, San Carlos, CA). cDNA output was analyzed for correct 
size distribution with an Experion Standard Sensitivity RNA chip and quantified using a 
Qubit Fluorometer (Invitrogen, Carlsbad, CA). Strand-specific sequencing libraries were 
produced using the NuGen Encore NGS Library I kit. Libraries were multiplexed and 
sequenced on an Illumina HiSeq 2500 at The Jackson Laboratory Genomic Medicine 
Sequencing Core. 2X50bp paired-end reads from each individual library were mapped 
with Tophat2 RNA-Seq spliced reads mapper (version 2.0.5) (Kim, Pertea et al. 2013) 
with parameter settings adjusted to suit strand-specific pair-end reads. The resulting bam 
files were used as input to the HTSeq high-throughput sequencing data analysis package 
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(Lister, Gregory et al. 2009) to quantify the read counts mapped to all genes in UCSC 
mm9 mouse gene annotation set. Mapped read counts were normalized using DESeq2 
(function: estimateSizeFactor) (Anders and Huber 2010). Genes were considered 
expressed if the number of reads was above the 25th percentile for the normalized data 
set. For quality control, only replicates with Pearson correlation coefficient above 0.9 on 
their FPKM values were considered (Figure 1). Expressed genes were then further 
analyzed for differential gene expression using the DEseq2 package with FDR cutoff: 0.1. 
Differential gene expression was calculated in WT BMDMs stimulated 10:1 with Bb 
relative to unstimulated WT BMDMs and MyD88-/- BMDMs stimulated 100:1 with Bb 
relative to unstimulated MyD88-/- BMDMs. Differentially expressed genes (DEGs) were 
classified as either upregulated or down regulated based on log2 fold change compared 
to the unstimulated control, which was calculated in R statistical software using package 
“DESeq2”. Determined DEGs were then separated into five groups based on their 
expression profiles; WT (all DEGs in WT BMDMs), MyD88-/- (all DEGs in MyD88-/- 
BMDMs), MyD88-dependent (all DEGs in WT but not MyD88-/- BMDMs), MyD88-
independent (all DEGs in both WT and MyD88-/- BMDMs), and MyD88-exclusive (all 
DEGs in MyD88-/- but not in WT BMDMs). 
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Figure 1:  Correlation of reads of RNA sequencing data. (A-D) Correlation of reads of 
RNA isolated from Bb-stimulated BMDMs. WT BMDMs were stimulated at a MOI 10:1 for 
6 hours (A). MyD88-/- BMDMs were stimulated at a MOI 100:1 for 6 hours (B).  To 
calculate differential expression, reads from the stimulated samples were normalized to 
unstimulated BMDMs of the same genotype; WT (C) or MyD88-/- (D) 
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IDENTIFICATION OF ENRICHED TRANSCRIPTION BINDING SITES AND MASTER REGULATOR 
ANALYSIS: 
Transcription factor binding sites in promoters of differentially-expressed genes were 
analyzed using known DNA-binding motifs described in the TRANSFAC library (Matys, 
Kel-Margoulis et al. 2006), release 2017.2, available in the GeneXplain software 
(http://genexplain.com). Binding site enrichment analysis for each one of our sets of 
DEGs was carried out as part of a GeneXplain dedicated workflow. The background 
consisted of 300 mouse house-keeping genes and the TRANSFAC mouse Positional 
Weight Matrices PWM (motifs) for binding site prediction with p-value<0.001 score cutoff. 
Promoters were extracted by the workflow with a length of 600 bp (−500 to +100) and an 
enrichment fold of 1.0.  
 
Master regulatory molecules were searched for in signal transduction pathways upstream 
of the identified TFs. The GeneXplain workflow available for this analysis was used in 
conjunction with the GeneWays database. Parameters set included a maximum radius of 
10 steps upstream of the TF nodes, the DEG lists from the respective group as context 
genes and a Z-score cutoff of 1.0. All transcription factors and master regulators used in 
the network analysis had confirmed expression in respective conditions using the total 
gene expression lists from the RNA-sequencing data set.  
 
GENE ONTOLOGY (GO) ENRICHMENT ANALYSIS: 
A Gene Ontology (GO) enrichment analysis was performed for the different sets of DEGs, 
transcription factors, and master regulators using the TRANSPATH (Krull, Pistor et al. 
2006) database through GeneXplain software. Input sets were the DEGs, transcription 
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factors, or master regulators from either the MyD88-dependent, MyD88-independent, or 
MyD88-privative groups. Focus was directed to the Gene Ontology (GO) biological 
processes output. GO biological processes related to Bb uptake, inflammation, and 
chemotaxis were identified by first reviewing previous studies for any genes involved in 
response to Bb relating to these phenotypes. Enrichment analysis was done on these 
genes to identify GO biological processes that hit at least 60% of the genes on the list, 
generating a list of relevant GO biological processes. Then an intersection was performed 
between the list of GO biological processes identified using our DEG, transcription factor, 
or master regulator lists, and the GO biological processes identified from the relevant 
genes. Heat maps of expressed genes hits in each biological process were done in R 
statistical software using package “ggplots”. 
 
NETWORK RECONSTRUCTION AND NETWORK ANALYSIS: 
Networks were constructed joining the three identified layers on the networks: DEGs, TFs 
and MRs. The subnetworks were extracted from identified master regulators of interest. 
From the MyD88-dependent master regulator group, effort was directed on linking MyD88 
with transcription factors that had binding sites in the promoter regions of the MyD88-
dependent DEGs enriched in uptake biological processes. These transcription factors 
were identified using the TRANSPATH database with the enriched DEGs of interest as 
input. The output list of transcription factors was intersected with the list of transcription 
factors that were only expressed in WT BMDMs. Networks were assembled and analyzed 
using Cytoscape software (Shannon, Markiel et al. 2003). To extract the desired 
subnetworks, we used OCSANA (Vera-Licona, Bonnet et al. 2013) within the BiNOM 
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plugin (Zinovyev, Viara et al. 2008) in Cytoscape 2.8.3. MyD88 was considered as a 
source node and transcription factors from the intersected list as target nodes. For 
MyD88-privative chemotaxis subnetwork construction the same analysis pipeline was 
applied. MyD88-privative master regulators significantly enriched in chemotaxis were 
used as source nodes and MyD88-privative transcription factors enriched in chemotaxis 
were used as targets.   
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CHAPTER 3: THE ROLE OF MYD88 IN MURINE INFLAMMATION 
DURING INFECTION WITH BORRELIA BURGDORFERI 
 
IMPORTANCE 
The macrophage is an essential element of the inflammatory cell infiltrate in tissues of 
mice experimentally infected with Bb (Montgomery, Booth et al. 2007, Hawley, Navasa et 
al. 2012), but its role in spirochetal clearance and tissue inflammation, as well as the 
importance of MyD88 in these processes, has not been well characterized. The purpose 
of the following experiments was to investigate whether MyD88 affects macrophage 
infiltrate into tissues during Bb infection and how this contributes to inflammation severity, 
tissue response and bacterial clearance.  
 
RESULTS 
MyD88 signaling significantly reduces bacterial load in tissues of Bb-infected mice.  
To determine the role of MyD88 in Bb clearance from infected tissues, we first used a 
well-defined murine model of LD that enables investigation of cell populations in tissues, 
transcript responses and bacterial clearance. For these experiments we needle-
inoculated WT and MyD88-/- mice with Bb and quantitated bacterial burdens in heart, 
patellofemoral joints, bladder, ear and skin tissues at 14-, 28- and 56-days post-infection 
(DPI). By 14 days, all experimentally infected mice seroconverted based on immunoblot 
analysis (data not shown). As shown in Figure 1, Bb disseminated to all tissues in both 
WT and MyD88-/- mice. In heart tissue, MyD88-/- mice showed significantly increased 
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bacterial burdens compared to WT mice at 14 and 28 DPI (Figure 1A); this difference 
was not significant by 56 DPI. The overall Bb burdens in heart tissue were lower than the 
other tissues studied (Figure 1). In patellofemoral joint, tibiotarsal joint, bladder, ear and 
skin tissues, burdens in WT and MyD88-/- mice were comparable at 14 DPI, but 
significantly higher in MyD88-/- mice at 28 and 56 DPI (Figure 1B-E).  We also saw a 
significant decrease in bacterial burdens in WT mice in all tissues except heart between 
14 and 56 DPI (Figure 1B-E). Taken together, our results substantiate that MyD88 
signaling is essential for Bb control in murine joint, skin, bladder and ear tissue. However, 
our results also show that in heart tissue MyD88-independent mechanisms can also 
mediate effective, though delayed, bacterial clearance.  
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Figure 1: MyD88-/- mice show increased Bb burdens 28 and 56 DPI (A-F) Bb burdens 
in selected mouse tissues as determined by RT-PCR. Mice were syringe-inoculated with 
105 Bb914 and sacrificed 14, 28 or 56 DPI. DNA was isolated from WT (black bars) and 
MyD88-/- (red bars) mice. Copies of flaB were normalized to Nidogen amplified from total 
tissue DNA in heart (A), tibiotarsal joint (B), patellofemoral joint (C), skin (D), ear (E), and 
bladder (F). n=3-5 mice per group *p-value<0.05, **p-value<0.01, NS=not significant, #p-
value<0.05 using Mann-Whitney test against WT 14 DPI burden values 
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Bb-driven MyD88-independent mechanisms are associated with inflammation 
severity in heart tissue.  
To study the severity of inflammation in Bb-infected murine hearts, we first examined the 
cellular infiltrates at 14 and 28 DPI by hematoxylin and eosin (H&E) staining. The 
histopathology of infected hearts consisted of lymphocytes, plasma cells, macrophages, 
reactive mesothelial cells, and fibroblasts. In more intensely inflamed heart tissue, 
neutrophils were also a significant component of the cellular infiltrate (Figure 2A). 
Inflammation was primarily evident in connective tissue at the heart base, especially 
around the root of the aorta, and in the atrial epicardium with some involvement of the 
atrial myocardium, valve leaflets and ventricular epicardium. Similar numbers of WT (2/5) 
and MyD88-/- (2/5) infected mouse hearts had evidence of low-grade inflammation 
(scores of 0-1) by 14 DPI (Figure 2A). Infected WT hearts showed stromal cell thickening 
at the base (Figure 2A, top panels), whereas a neutrophil infiltrate was clearly evident 
in the heart of one MyD88-/- infected mouse 14 DPI (Figure 2A, inset). Importantly, 
inflammation scores between the two genotypes were not significantly different at 14 DPI 
(Figure 2B). By contrast, 28 DPI the majority of MyD88-/- mice (4/5) showed significantly 
increased cellular infiltrates (Figure 2C, bottom panels) and high inflammation scores 
(Figure 2D), whereas only 2/5 WT mice revealed evidence of inflammation. Hearts from 
MyD88-/- mice also revealed the presence of neutrophils as part of the inflammatory 
infiltrate (Figure 2C, bottom panels and inset) whereas WT mice did not. (Figure 2C, 
top panels).  
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Figure 2: MyD88-/- mice show increased inflammation severity and macrophage 
infiltrate 28 days post Bb-infection. (A and C) Representative images of H&E staining 
of heart tissue sections from WT and MyD88-/- mice syringe-inoculated with 10e5 Bb at 
14 DPI (A) and 28 DPI (C). Images are of increasing magnification from left to right (10x, 
20x, 40x, inset is 60x). Sections are 5 m. (B and D). Compilation of inflammation scores 
for WT (black dots) and MyD88-/- (red dots) mice at 14 DPI (B) and 28 DPI (D) N=5 mice 
per group. 
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The absence of MyD88 affects expression of genes associated with inflammation 
but does not increase inflammation severity or infiltration of macrophages in joints. 
We next examined joints using an approach similar to that described above for hearts. 
Inflamed joints had small numbers of neutrophils, lymphocytes, plasma cells and 
macrophages (Figure 3A and 3C). This infiltrate was most commonly evident in the joint 
capsule near the junction with the periosteum. More prominent mixed inflammatory 
infiltrates were generally present in the periarticular loose connective tissue, especially in 
fat and along the periosteum, extending from the joint. A low-grade immune cell infiltrate 
was observed in most WT (3/5) and all MyD88-/- (5/5) mouse joints 14 DPI (Figure 3A). 
Similar to heart tissue, no differences in inflammation score between WT and MyD88-/- 
joints were observed 14 DPI (Figure 3B). The number of WT (3/5) and MyD88-/- (5/5) 
mice presenting with inflammation 14 DPI also were comparable (Figure 3B). In contrast 
to hearts, inflammation severity in joints was minimal to mild at 28 DPI in both genotypes, 
with no appreciable differences in the cell types present (Figure 3C, bottom panels). 
Inflammation scores also were comparable between WT and MyD88-/- mice; no 
significant difference in the number of mice showing inflammation was noted (WT = 2/5, 
MyD88-/- = 3/5) (Figure 3D).  
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Figure 3: MyD88-/- mice show comparable inflammation and macrophage infiltrate 
in knee joint tissue 14 and 28 days post Bb-infection. (A and C) Representative 
images of H&E staining of knee joint tissue sections from WT and MyD88-/- mice syringe-
inoculated with 10e5 Bb at 14 DPI (A) and 28 DPI (C). Images are of increasing 
magnification from left to right (10x, 20x, 40x). Sections are 5m. (B and D) Compilation 
of inflammation scores for WT (black dots) and MyD88-/- (red dots) mice at 14 DPI (B) 
and 28 DPI (D) N=5 mice per group. *p-value<0.05, **p-value<0.01, NS=not significant 
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Macrophage infiltration is dramatically increased in MyD88-/- heart tissue but not 
joint tissue 
Because macrophages are not easily distinguishable by H&E staining, we performed 
immunohistochemistry (IHC) analysis for Iba-1, a calcium channel marker known to be 
expressed in macrophages (Utans, Arceci et al. 1995). Both WT and MyD88-/- infected 
and uninfected hearts revealed Iba-1+ macrophages throughout the myocardium, as 
would be expected in normal murine hearts (Keller and Maniatis 1991, Utans, Arceci et 
al. 1995). By 14 DPI, small numbers of macrophage clusters were observed in the heart 
base in WT mice (Figure 4A, top left), while no increase in macrophages was observed 
in MyD88-/- hearts 14 DPI (Figure 4A, top right). On the other hand, 28 DPI MyD88-/- 
mouse hearts revealed a very dense macrophage infiltrate at the base (Figure 4A, 
bottom right). We also performed Iba-1 IHC on patellofemoral joint tissue sections and 
visualized a few macrophages in the periarticular space in both WT and MyD88-/- mice 
14 DPI (Figure 4B, top panels) and 28 DPI (Figure 4B, bottom panels). However, no 
difference in the number of macrophages infiltrating joint tissue was apparent between 
the two genotypes at the time points studied. Our IHC findings suggest that although 
infiltration is delayed in the absence of MyD88, murine macrophages are significant 
contributors to the inflammatory response in heart tissue and, by extension, Lyme carditis. 
 45 
 
Figure 4: MyD88-/- mice show increased macrophage infiltrate 28 days post Bb-
infection. (A) Iba-1 immunohistochemistry of heart tissue sections from Bb-infected WT 
and MyD88-/- mice. (B) Iba-1 immunohistochemistry of knee joint tissue sections from 
Bb-infected WT and MyD88-/- mice, magnification = 20x. Sections are 5m. 
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The absence of MyD88 drives unique chemokine transcript expression profiles in 
heart tissue during Bb infection. 
Our results above show that MyD88 signaling affects type and quantity of inflammatory 
cells recruited to heart tissue during Bb infection. To gain further insight into how these 
cells are responding to Bb, we performed RT-PCR of selected genes from total RNA 
isolated from heart tissues from Bb-infected mice. We focused on various groups of genes 
related to inflammation; NFB-mediated cytokines (Tnfa and Il1b), type I interferons, 
components of the inflammasome (Nod2, Nlrp3, Casp1) and chemokines (Ccl2, Ccl9, 
Cxcl2, Cxcl3, Cxcl10). We also included Aif1, which translates into Iba-1, and Itgam, also 
known integrin alpha M or CD11b, which has been previously identified as a phagocytic 
receptor for Bb (Hawley, Olson et al. 2012). As shown in Figure 5A, significant 
transcriptional differences between WT and MyD88-/- mice were seen 14 DPI, with WT 
hearts showing marked upregulation of all genes tested in comparison to uninfected WT 
controls. In contrast to WT mice, several genes in MyD88-/- infected hearts were down-
regulated at 14 DPI compared to uninfected controls, including Ccl9, Cxcl2, Cxcl3 and 
Cxcl10, as well as genes involved in inflammasome activation (Nod2, Nlrp3 and Casp1) 
(Figure 2F). However, four out of five MyD88-/- hearts showed upregulation of Ccl2, a 
macrophage-specific chemokine (Mantovani, Sica et al. 2004), and two MyD88-/- mouse 
hearts showed upregulation of Itgam at 14 DPI (Figure 5A). At 28 DPI, Ccl2 and Ccl9, 
another macrophage-specific chemokine (Mantovani, Sica et al. 2004), were upregulated 
in all MyD88-/- heart tissues studied (Figure 5B). Three out of five MyD88-/- mice also 
showed upregulation of Ifnb. By contrast, Ccl9, Ccl2 and Ifnb were down-regulated in WT 
hearts 28 DPI, and not surprisingly WT mice still showed significant up-regulation of 
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MyD88-dependent pro-inflammatory genes (i.e. Tnfa) (Adachi, Kawai et al. 1998) (Figure 
5B). At 28 DPI, WT mice also showed upregulation of Ncf2, which codes for Neutrophil 
Cytosol Factor 2, a subunit of NADPH oxidase that can indicate the presence of 
neutrophils in the tissue (Mantovani, Sica et al. 2004), and Aif1 (Figure 5B). All MyD88-
/- mice showed down-regulation of Ncf2 and Aif1 at 28 DPI; this finding was surprising 
given the increased neutrophilic infiltrate and Iba-1-positive macrophage infiltrate seen in 
the MyD88-/- mice by IHC. Overall, these data suggest that in the absence of MyD88, 
cells in heart tissue show different inflammatory gene expression in response to Bb, with 
increased macrophage chemokine production that can facilitate their recruitment. 
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Figure 5: MyD88-/- mice show decreased proinflammatory cytokine production but 
increased tissue-specific chemokine production. (A and B) Compilation of multiple 
qRT-PCR gene amplifications from heart tissue RNA. Total RNA was isolated from Bb-
infected WT and MyD88-/- mice 14 (A) and 28 (B) days post infection. (C and D) 
Compilation of multiple qRT-PCR gene amplifications from tibiotarsal joint tissue RNA. 
Total RNA was isolated from Bb-infected WT and MyD88-/- mice 14 (C) and 28 (D) days 
post infection. Gene amplification values were normalized to Gapdh. Heat map shows z-
score relative to the row mean. *p-value<0.05, **p-value<0.01, NS=not significant 
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Transcript production of multiple chemokines are upregulated in MyD88-/- joint 
tissue during Bb infection. 
We also performed targeted qRT-PCR on total RNA isolated from tibiotarsal joints of Bb-
infected mice as described above for hearts. At 14 DPI we saw upregulation of 
inflammatory genes in both WT and MyD88-/- mice compared to respective uninfected 
controls, but no significant differences were observed between the two groups (Figure 
5C and 5D). However, there were noticeable differences between WT and MyD88-/- mice 
at 28 DPI. WT mice showed upregulation of NFkB-mediated cytokines including Tnfa, Il1b 
and Mmp9 (a matrix metalloproteinase shown to be upregulated in murine joint tissue in 
Bb infection (Gebbia, Coleman et al. 2001)) and inflammasome genes, which were 
downregulated in MyD88-/- mice (Figure 5D). By contrast, MyD88-/- mice showed 
significant upregulation of the chemokines Ccl2, Ccl9, Cxcl2, and Cxcl10 (Figure 5D) 
compared to uninfected controls. These chemokines were downregulated overall in WT 
mice. Interestingly, Cxcl2 and Cxcl10 were not significantly upregulated in heart tissue at 
the same time point (Figure 5B). These chemokines have high affinity for the IL-8 
receptor (Ahuja and Murphy 1996), and may facilitate recruitment of other inflammatory 
cells (besides macrophages) to joint tissue in the absence of MyD88. Despite the lack of 
macrophage infiltrate seen in joint tissue, Aif1 was significantly upregulated in WT joints 
14 DPI and MyD88-/- joints 28 DPI (Figure 5D). This is consistent with heart tissue, where 
Aif1 was transcriptionally upregulated in absence of increased macrophage infiltrate 
(Figure 5B) and suggests that there is another cell type in the joint which could be 
upregulating Aif1 transcription (Pawlik, Kotrych et al. 2016). Taken together these data 
support that there are MyD88-independent tissue specific responses to Bb infection.
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CHAPTER 4: THE ROLE OF MYD88 IN RECOGNITION AND UPTAKE 
OF BORRELIA BURGDORFERI BY MURINE MACROPHAGES 
 
IMPORTANCE 
Once spirochetes are phagocytosed by macrophages, recruitment of TLR and MyD88 
proteins to the phagosome is essential to trigger MyD88-dependent signaling cascades.  
Importantly, we have demonstrated that in human monocytes TLR2 and TLR8 are 
recruited to endosomes containing Bb (Cervantes, Dunham-Ems et al. 2011). The 
purpose of the following experiments was to determine the effect of MyD88 on Bb uptake 
kinetics by macrophages, establish localization of TLR2, TLR7 and MyD88 to Bb-
containing phagosomes, investigate the importance of MyD88 in phagosome maturation 
for spirochete degradation, and determine whether MyD88-independent signaling occurs 
from the phagosome. 
 
RESULTS 
MyD88-deficient macrophages show comparable binding but reduced uptake of Bb 
To better understand the contribution of MyD88 to spirochete binding, uptake and 
degradation by macrophages, we transitioned into an ex vivo macrophage model using 
WT and MyD88-/- BMDMs co-incubated with Bb at MOIs of either 10:1 or 100:1 for 1, 4 
or 6 hours. To quantify binding percentages, we imaged a minimum of 100 cells by 
confocal microscopy and from the images determined the number of cells with 
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spirochetes either attached to the surface or internalized (Figure 1A, yellow and white 
arrows respectively). We used the same confocal images and total cell numbers to 
quantify uptake percentages based on the number of cells with internalized spirochetes. 
The percentage of cells with spirochetes either bound or internalized was comparable 
between WT and MyD88-/- BMDMs at all three time points irrespective of MOI (Figure 
1B and 1C). While macrophages of both genotypes were able to phagocytose Bb, 
MyD88-/- BMDMs showed significantly reduced spirochete uptake compared to WT 
BMDMs (Figure 1D). While increasing the MOI to 100:1 significantly enhanced uptake in 
both cell genotypes, MyD88-/- BMDMs never reached the phagocytic potential of their 
WT counterparts (Figure 1E).  
 52 
 
Figure 1: Quantitation of Bb binding and uptake by WT and MyD88-/- BMDMs. (A) 
Confocal images of WT and MyD88-/- BMDMs after 6 hours of stimulation with Bb at MOI 
10:1, highlighting bound (yellow arrows) and internalized (white arrows) spirochetes. 
Green is Bb, red is actin and blue is cell nucleus. (B-C) Quantitation of bound (B) or 
internalized (C) spirochetes to WT (black bars) or MyD88-/- (red bars) BMDMs after 1, 4 
or 6 hours of stimulation at a MOI of 10:1. (D-E) Quantitation of bound (D) or internalized 
(E) spirochetes to WT (black bars) or MyD88-/- (red bars) BMDMs after 1, 4 or 6 hours of 
stimulation at MOI 100:1. (F) Comparison of Bb internalization by WT BMDMs (black 
bars) at MOI 10:1 with MyD88-/- BMDMs (red bars) at MOI 100:1. n=3-5 mouse BMDM 
experiments per genotype *p-value<0.05, **p-value<0.01, ***p-value<0.001, NS=not 
significant 
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TLR2, TLR7 and MyD88 are recruited to Bb-containing phagosomes in 
macrophages 
To determine whether in mouse macrophages TLRs also co-localize to phagosomes to 
contribute to inflammatory signaling, we next characterized co-localization of TLR2, TLR7 
and MyD88 with phagosomes containing Bb in BMDMs. Given that murine TLR8 does 
not seem to utilize ssRNA as its ligand (Heil, Hemmi et al. 2004), we investigated the 
presence of TLR7 in the phagosome, which also utilizes bacterial ssRNA as its ligand. In 
addition, other groups have shown a prominent role for TLR7 in the Bb inflammatory 
response (Petzke, Brooks et al. 2009). By confocal microscopy, we showed that in WT 
BMDMs there is recruitment of MyD88 (Figure 2A) and TLR2 (Figure 2B) to Bb-
containing phagosomes. Signals from MyD88 and TLR2 distinctly overlay with Bb-
containing phagosomes in both coiled and degraded states (Figure 2A and B, graphs). 
However, greater fluorescence intensities of MyD88 and TLR2 were observed 
colocalizing with degraded phagosomes rather that coiled phagosomes, indicating that 
as more Bb ligand is exposed through phagosome maturation more of each of these 
markers are recruited. We also saw significant colocalization of TLR7 with Bb-containing 
phagosomes (Figure 2C). However, colocalization of TLR7 was only observed with 
degraded phagosomes (Figure 2C). In MyD88-/- BMDMs there is still recruitment of TLR2 
to the phagosome (Figure 3A), but TLR2 recruitment is not associated with pro-
inflammatory signaling due to the lack of functional MyD88 protein (Adachi, Kawai et al. 
1998). We also saw no difference in colocalization of TLR2 (Figure 3B) or MyD88 (Figure 
3C) with either elongated Bb on the cell surface, coiled Bb in early endosomes, or 
degraded Bb in late endosomes. There was also no difference in cell surface area 
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between WT and MyD88-/- BMDMs after Bb stimulation for 1 hour (Figure 3E). Taken 
together, these data confirm that endosomal TLR2, TLR7 and MyD88 colocalize to Bb-
containing phagosomes to facilitate recognition of bacterial ligands and early response to 
infection.  
 55 
 
Figure 2: MyD88, TLR2 and TLR7 colocalize with Bb in phagosomes. (A-C) Confocal 
images and colocalization analysis of internalized Bb with MyD88 (A), TLR2 (B) or TLR7 
(C) in WT BMDMs after stimulation at MOI 10:1. White box indicates phagosome depicted 
in inset. Large inset in (B) shows coiling pseudopod formation around Bb on cell surface. 
Graph shows the intensity of each indicated pixel marker across the white line (distance 
on x-axis). Green is Bb, blue is MyD88 (A), TLR2 (B) or TLR7 (7), and red is actin. 
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Figure 3: TLR2, MyD88 and TLR7 colocalize to both bound and degraded Bb in 
BMDMs. (A) Confocal images and colocalization analysis of internalized Bb with TLR2 in 
MyD88-/- BMDMs after 1 hour of stimulation at MOI 10:1. White box indicates phagosome 
depicted in inset. Graph shows the intensity of each indicated pixel marker across the 
white line (distance on x-axis). Green is Bb, blue is TLR2, and red is actin. (B-C) 
Quantitation of colocalization coefficients between Bb and TLR2 (B) or MyD88 (C) during 
different phagosome stages. (D) Measurement of cell surface area using Actin staining, 
comparing WT and MyD88-/- BMDMs after 1 hour of Bb stimulation. 
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Lack of MyD88 does not affect degradation of Bb in the phagosome 
Given that both WT and MyD88-/- BMDMs bind and internalize Bb, we next sought to 
determine if spirochetes are similarly degraded in phagosomes with and without MyD88. 
Confocal images taken after a 6-hour stimulation at MOI 10:1 showed that both WT and 
MyD88-/- BMDMs contained Bb (GFP+) blebs within the cell actin matrix (Figure 4A). To 
assess phagosome maturation, we quantitated recruitment of Lysosome-Associated-
Membrane-Protein-1 (LAMP-1), which is a marker of endosome maturation, to Bb-
containing phagosomes by looking at colocalization of LAMP-1 and GFP fluorescence 
intensity (Westphal, Cheng et al. 2017). Both WT and MyD88-/- BMDMs showed 
comparable LAMP-1 and Bb colocalization in phagosomes (Figure 4A, graphs). 
Colocalization between Bb and LAMP-1 was measured in multiple phagosomes in 
BMDMs from both genotypes and no significant differences were found (Figure 4B). To 
test for the presence of phagosome leakage, we measured cleaved Caspase-1, which is 
indicative of inflammasome activation by recognition of lysosomal contents in the cytosol. 
Western blot analysis of WT BMDM cell lysates and supernatants showed no activation 
of Caspase-1 by stimulation of Bb alone (Figure 4C), which is consistent with previously 
published studies (Oosting, van de Veerdonk et al. 2011). However, in discordance with 
previous studies (Oosting, Berende et al. 2010), we did not see cleavage of IL-1 (Figure 
4C). To confirm MyD88 signaling in response to Bb we also measured TNF secretion 
after 1, 4 and 6 hours of incubation with spirochetes. We also confirmed lack of assembled 
inflammasome activation by staining WT BMDMs for ASC 30 minutes and 6 hours after 
Bb stimulation (Figure 5B and 5D). As a positive control, we also performed ASC staining 
on WT BMDMs stimulated with Staphylococcus aureus (Sa), which has been previously 
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shown to induce inflammasome activation (Sokolovska, Becker et al. 2013) (Figure 5A 
and 5C). While Sa induced high amounts of ASC in WT BMDMs both 30 minutes and 6 
hours post-stimulation, Bb did not (Figure 5). This further confirms that Bb does not 
induce leakage of phagosome cargo into the cytosol. WT BMDMs showed significant 
increase in TNF secretion in the presence of spirochetes, while MyD88-/- BMDMs did 
not make TNF protein (Figure 6A). MyD88-/- BMDMs also did not secrete IL-6, IL-10 or 
IL-12 (Figure 6). In line with our experiments in vivo and consistent with prior studies by 
Behera et al. (2016), both WT and MyD88-/- BMDMs secrete the macrophage chemokine 
CCL2 (Figure 6D). Taken together, these data suggest that even in the absence of 
MyD88 there is still uptake (although reduced) and sufficient degradation, creating 
potential for recognition of Bb ligands solely within the phagosome. 
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Figure 4: Colocalization of phagosome markers with internalized Bb in WT and 
MyD88-/- BMDMs. (A) BMDMs after 6 hours of stimulation with Bb at MOI 10:1, depicting 
colocalization of Bb-containing phagosomes with LAMP-1. White box indicates phagosome 
depicted in inset. Graph shows the intensity of each indicated pixel across the white line 
(distance on x-axis). Green is Bb, red is LAMP-1 and yellow is actin. (B) Quantitation of 
colocalization between Bb and LAMP-1 in 10 phagosomes of WT (black dots) and MyD88-
/- (red dots) BMDMs by measuring intensity overlap between LAMP-1 staining and Bb 
staining. (C) Western blot of protein lysate isolated from WT BMDMs after 6-hour stimulation 
with Bb +/- ATP (C=cell lysate, S=supernatant). 
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Figure 5: Bb does not induce ASC formation in BMDMs. (A-D) Confocal images (40x) 
of BMDMs stimulated with either Bb (B and D) or Sa (A and C) for 1 hour (A-B) or 6 hours 
(C-D). Blue is nucleus, red is ASC and green is the bacteria species. 
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Figure 6: MyD88-/- BMDMs stimulated with Bb show abrogated cytokine 
production. (A-D) Quantification of CCL2 (A), IL-12 (B), IL-6 (C) and IL-10 (D) proteins 
in supernatant from WT and MyD88-/- (MyD) BMDMs stimulated with Bb at MOI 10:1 for 
1, 4 or 6 hours. N= 3 mouse BMDM per genotype *p-value<0.05, **p-value<0.01, ***p-
value<0.001, NS=not significant 
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Signaling cascades induced in the absence of MyD88 are still triggered from the 
phagosome 
The signaling pathways described above illustrate potential mechanisms that 
inflammatory genes can be induced in the absence of MyD88. However, previous studies 
indicate that phagocytosis is critical to induce a robust cytokine response to the 
spirochete, even in the presence of MyD88 (Moore, Cruz et al. 2007). To determine 
whether MyD88-dependent inflammatory signals are enhanced by phagocytosis, we 
stimulated WT and MyD88-/- BMDMs with Bb in the presence or absence of Cytochalasin 
D, which blocks phagocytosis. We then measured transcript production of chemokines 
identified in our RNA-sequencing data as MyD88-independent and which also were 
significantly altered in the tissue microarray. Absence of Bb uptake in BMDMs in 
Cytochalasin-D treated cells was confirmed by confocal microscopy (data not shown). In 
WT BMDMs significant transcript reduction of Ccl9 (Figure 7A), Cxcl2 (Figure 7B), Cxcl3 
(Figure 7C), and Cxcl10 (Figure 7D) was observed 1-, 4- and 6-hours post-stimulation. 
Similar reduction was also observed in MyD88-/- BMDMs at each time point (Figure 7). 
While there was a significant increase of MyD88-independent pro-inflammatory 
chemokines in both WT and MyD88-/- BMDMs, the increase was more pronounced in 
WT BMDMs. We also measured production of MyD88-dependent transcripts that we have 
previously shown to be abrogated in BMDMs pre-treated with Cytochalasin-D and 
stimulated with Bb (Moore, Cruz et al. 2007). Significant reduction of Tnfa (Figure 7E), 
and Il6 (Figure 7F was observed in WT BMDMs pre-treated with Cytochalasin-D. As 
expected, production of these transcripts was not observed in MyD88-/- BMDMs (Figure 
7). These results suggest that while, in response to Bb, pro-inflammatory chemokine 
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production by BMDMs does not require MyD88, it does require uptake of the spirochete 
into the phagosome for signaling cascades to be triggered.  
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Figure 7: MyD88-independent chemokine production requires uptake of Bb. (A-D) 
Transcript analysis of WT (black and white bars) and MyD88-/- (red and blue bars) 
BMDMs stimulated with Bb in the presence or absence of Cytochalasin D for 1, 4 or 6 
hours. Cells were pre-treated with Cytochalasin D for 1 hour prior to addition of Bb. 
Transcript production of Ccl9 (A), Cxcl2 (B), Cxcl3 (C), Cxcl10 (D), Tnfa (E) and Il6 (F) 
were measured by qRT-PCR from total BMDM RNA. *p-value<0.05, **p-value<0.01, ***p-
value<0.001, NS=not significant 
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CHAPTER 5: MYD88 DEPENDENT AND INDEPENDENT 
PHAGOSOMAL SIGNALING IN MURINE MACROPHAGES 
IMPORTANCE 
Our results in the preceding chapters emphasize the changes in inflammatory cell 
infiltrate and chemokine upregulation in tissues due to MyD88 signaling and show that 
MyD88 enhanced the capacity of macrophages to capture spirochetes. The purpose of 
the following experiments was to investigate MyD88-independent inflammatory 
responses and MyD88-dependent signaling in driving enhanced phagocytosis. To 
accomplish this, we used an RNA-sequencing approach (see methods in Chapter 2 and 
Figure 1) on Bb-stimulated BMDMs. 
 
RESULTS 
MyD88-dependent signaling causes differential expression of genes in 
macrophages that promote the inflammatory response. 
To gain a better understanding of events that occur downstream of signaling by MyD88 
which result in this phenotype presentation, we performed RNA sequencing on WT and 
MyD88-/- BMDMs stimulated with Bb for 6 hours. This time point was selected based on 
data showing comparable maturation in both WT and MyD88-/- BMDM phagosomes 
(Figure 2A). To establish comparable levels of phagocytic cargo despite the reduced 
uptake seen in the absence of MyD88, we stimulated WT BMDMs at a MOI of 10:1 and 
MyD88-/- BMDMs at a MOI of 100:1. The uptake percentages were not significantly 
different between the two cell phenotypes under these conditions. Both WT and MyD88-
/- BMDMs showed differentially expressed genes (DEGs) when compared to their 
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respective unstimulated controls. We noted that the number of DEGs in WT BMDMs was 
much higher compared to MyD88-/- BMDMs (2818 genes vs 141 genes respectively) 
(Figure 2B). We saw similar numbers of up- and down-regulated DEGs in WT BMDMs 
(Figure 2B). In the MyD88-/- BMDMs, approximately 83% of the DEGs were up-regulated 
(Figure 2B). We classified the DEGs into three categories for further analysis: genes 
differentially expressed only in WT BMDMs (MyD88-dependent); genes differentially 
expressed in both WT and MyD88-/- BMDMs (MyD88-independent); and genes that were 
differentially expressed only in MyD88-/- BMDMs (MyD88-privative) (Figure 2C).  
 
Using these data, we performed a Gene Ontology (GO) enrichment analysis of each 
group of DEGs (Figure 2). Because we showed above that in macrophages MyD88 
affects both the inflammatory response and uptake of spirochetes we focused on 
biological processes relating to inflammation and phagocytosis in the MyD88-dependent 
DEGs. Multiple inflammatory biological processes were enriched (see supplemental files) 
but we concentrated on five processes with high numbers of gene hits: (i) Positive 
Regulation of Immune System Process; (ii) Positive Regulation of Cytokine Production; 
(iii) Immune System Process; (iv) Immune Response; and (v) Defense Response. The 
MyD88-dependent GO analysis resulted in the DEGs being broadly characterized into 
two different subsets. The first is comprised of DEGs enriched in all or almost all five 
processes and includes classic inflammatory genes, such as Il6, Il12b, Il1b, Il23a and Tlr9 
(Figure 2D). The second is comprised of DEGs that were enriched in only one or two of 
the five biological processes (Figure 2D). Examples of these DEGs included Prdm1 
(Positive Regulation of Immune System Process), which is involved in suppression of 
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IFN- production (Keller and Maniatis 1991) and Il17ra (Positive Regulation of Cytokine 
Production), which facilitates the differentiation of neutrophils in response to IL-17 (Yao, 
Spriggs et al. 1997). The MyD88-independent DEGs also significantly enriched to the 
same five biological processes in their GO analysis but had fewer numbers of hits for 
each process. The GO analysis of the MyD88-privative genes also showed significant 
enrichment to four of these inflammatory processes; Positive Regulation of Cytokine 
Production was not enriched in the MyD88-privative DEGs. Overall this analysis indicates 
that MyD88 signaling triggers a more robust transcriptional inflammatory response to Bb 
which involves many processes and cellular elements that can result in immune cell 
activation. 
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Figure 1: Analysis pipeline for analysis of RNA sequencing data. Based on identified 
DEGs transcription factors were mapped to promotor regions using the TRANSFAC 
database. Once transcription factors were identified for each subgroup of DEGs, master 
regulators were identified using the GeneWays database, using a list of known proteins 
expressed in MyD88-/- BMDMs as context genes. At each step of analysis (DEG, 
transcription factor, master regulator) an enrichment analysis for biological processes 
was completed and intersected with the list of relevant biological processes. The gene 
hits for each biological process were then merged into one list and exported into a heat 
map to determine whether they were up or down regulated. 
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Figure 2: MyD88-dependent DEGs are significantly enriched in biological 
processes related to inflammation and uptake. (A) Bb uptake comparison between 
WT BMDMs stimulated at a MOI 10:1 and MyD88-/- BMDMs stimulated at a MOI 100:1 
for 6 hours. (B) Number of differentially expressed genes (DEGs) in Bb-infected WT and 
MyD88-/- BMDMs determined by RNA-sequencing. Red bar indicates number of 
upregulated DEGs and blue bar indicates number of down-regulated DEGs. Bar height 
represents total number of DEGs in each condition. (C) Venn diagram depicting DEG 
classification. MyD88-dependent genes (light gray, left) are only differentially expressed 
in WT BMDMs. MyD88-independent genes (center) are expressed in both cell types. 
MyD88-privative genes (dark gray, right) are only differentially expressed in MyD88-/- 
BMDMs. (D and E) Heat maps depicting fold-change values of MyD88-dependent DEGs 
enriched in specific biological processes. Red indicates positive fold-change increase, 
blue indicates negative fold-change increase, gray indicates no enrichment to biological 
process. (D) MyD88-dependent DEGs that significantly enriched to 5 indicated biological 
processes relating to inflammation. (E) MyD88-dependent DEGs that significantly 
enriched to 5 indicated biological processes relating to uptake. 
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Multiple genes associated with biological processes involved with phagocytosis 
are MyD88-dependent. 
Based on our observation that the presence of MyD88 enhances phagocytosis we also 
analyzed whether any of the MyD88-dependent DEGs enriched to biological processes 
related to pathogen uptake. We identified 164 MyD88-dependent DEGs that enriched to 
five different biological processes relating to phagocytosis (Actin Filament Polymerization, 
Regulation of Cell Shape, Actin Cytoskeleton Organization, Cytoskeleton Organization, 
and Actin Filament Organization) (Figure 2E). Of particular interest, Daam1 and Fmnl1, 
two genes shown to play a role in phagocytosis of Bb (Naj, Hoffmann et al. 2013, 
Hoffmann, Naj et al. 2014, Williams, Weiner et al. 2018), were differentially expressed in 
a MyD88-dependent manner (Figure 2E). Daam1, which was upregulated, is a formin 
protein that bundles actin fibers together to increase stability of coiling pseudopods, which 
are more adept at capturing the highly motile spirochetes (Naj and Linder 2017). Fmnl1, 
which was down-regulated, is also a formin protein that severs actin branches to promote 
polymerization and increase filopodia protrusion (Naj and Linder 2017, Williams, Weiner 
et al. 2018).To better understand how these genes relate to other genes commonly 
associated with phagocytosis, and to understand which pathways are turned on or off, we 
first separated the 164 genes into two groups based on upregulation or downregulation. 
We then entered the list of genes from each group into the GeneXplain software to 
determine how they interact with each other. Pathways including the uptake genes with 
up to 10 intermediates between them were computed. Because Daam1 and Fmnl1 have 
been previously implicated in phagocytosis of Bb, we then merged all pathways that 
included either Daam1 or Fmnl1 into networks (Figure 3).  The network mapping Daam1 
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chains (Figure 3A) shows related pathways that are upregulated and includes Rhoa, 
Akt1, Rac1 and Cdc42 as intermediates. Daam1 regulates Rhoa expression, which 
controls Cdc42, Rac1 and Akt1. Cdc42 is activating a Rho GTPase, Rhoq, which is 
upregulated in response to Bb. Rac1 and Akt1 both activate multiple genes that are also 
upregulated, indicating that while these intermediate proteins aren’t differentially 
expressed they are still active in macrophages that have been stimulated with Bb. In 
contrast to Daam1, Fmnl1 was downregulated in response to Bb. The network mapping 
Fmnl1 chains (Figure 3B) also highlights other pathways and genes that are 
downregulated. This network also includes Cdc42 and Akt1 as intermediate proteins. 
However, the network shows that the genes which inactivate these proteins are being 
downregulated in an MyD88-dependent manner. The downregulation of these inhibitors 
indicates that the activity of these proteins is important in the macrophage response to 
Bb, consistent with the Daam1 network above. Taken together, these data suggest that 
MyD88 signaling upregulates multiple genes involved in regulating macrophage 
membrane protrusions. Upregulation of these genes likely contributes to the 
reorganization of cell machinery that enhances the capability of the WT macrophage to 
take up spirochetes. 
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Figure 3: MyD88-dependent DEGs that significantly enrich to uptake processes 
show direct and indirect connections with key proteins involved in Bb 
phagocytosis. (A) Network of MyD88-dependent uptake DEGs that are upregulated. The 
varying degree of red or blue hue in select nodes correlates with the gene’s Log2 Fold 
Change value. Red indicates positive fold change and blue indicates negative fold 
change. Gray nodes represent genes that were not differentially expressed. (B) Network 
of MyD88-dependent uptake DEGs that are upregulated. The same parameters and color 
scale applied in (A) was used. 
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Similar inflammatory and chemotactic processes are enriched regardless of 
MyD88-mediated signaling, but utilize different regulatory proteins 
MyD88-dependent mechanisms of inflammation have been well characterized, but little 
work has been done to understand the drivers of Bb-induced inflammation in the absence 
of MyD88. To address this issue, we next completed a comprehensive analysis to 
determine how the DEGs are regulated within Bb-infected macrophages in the presence 
or absence of MyD88. We first identified transcription factors with potential binding sites 
in the promoter regions of the DEGs for each of the three subsets (66 MyD88-dependent, 
201 MyD88-independent, and 39 MyD88-privative). We then identified master regulator 
proteins upstream of these transcription factors and performed a GO enrichment analysis 
using the same parameters described in Figure 1. The enrichment analysis of MyD88-
independent master regulators revealed processes involved in cell metabolism and 
homeostasis, which did not give much insight into differences in mechanisms of 
inflammation driven by the presence or absence of MyD88. Therefore, we focused on 
analysis of MyD88-dependent and MyD88-privative master regulators. In light of our 
findings that Bb-infected MyD88-/- mice showed increased macrophage and neutrophil 
infiltrate in heart tissue, we investigated whether any master regulators enriched to 
inflammatory and/or chemotactic biological processes. Interestingly, similar biological 
processes significantly enriched in inflammation were both identified in the MyD88-
dependent (including MyD88, Irak2 and Ly96) and MyD88-privative (including Vcam1 and 
Cxcl2) master regulators (Figure 4A and 4C), but the individual master regulators 
involved were different for each subset (Figure 4A). Importantly, over three times as 
many master regulators were identified for the MyD88-dependent DEGs than the MyD88-
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privative DEGs (Figure 4C), suggesting that MyD88 signaling controls activation of more 
master regulators in the cell to initiate DEGs (see Figure 2) and enables the cell to 
perform unique processes in response to Bb.  
 
MyD88 is a master regulator for transcription factors that control the MyD88-
dependent DEGs enriched in uptake processes. 
To better understand the phenotypic differences related to phagocytosis between the two 
genotypes (see Figure 2), we identified transcription factors that map to promoter regions 
of DEGs related to phagocytosis. We then used OCSANA in Cytoscape to link MyD88 
(as a master regulator) with transcription factors that map to DEGs in this specific subset. 
Of these transcription factors, three were expressed exclusively in WT BMDMs; Zic1, 
Zeb1 and Gata3. Based on this information we constructed a network illustrating potential 
links between MyD88-mediated signaling and enhanced phagocytic capability seen in WT 
cells (Figure 4E). Of particular interest, the network predicts that Zic1, but not Zeb1 or 
Gata3, has the capacity to bind to the promoter regions of several of the MyD88-
dependent DEGs that significantly enriched to processes associated with bacterial 
uptake. Zic1 is controlled by the intermediate protein ApoE, which is known to play a role 
in cholesterol metabolism in macrophages (Toledo, Monzon et al. 2015) and the absence 
of ApoE increases Bb burdens in experimentally infected mice (Toledo, Monzon et al. 
2015).  
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Figure 4: Master regulators of MyD88-dependent and MyD88-privative DEGs 
control similar inflammatory processes but different chemotactic processes. (A 
and B) Venn diagrams comparing biological processes (BP) relating to inflammation (A) 
or chemotaxis (B) significantly enriched between MyD88-dependent (light gray) and 
MyD88-privative (dark gray) master regulators.  (C and D) Heat map showing fold change 
of master regulators enriched in inflammation (C) or chemotaxis (D) in WT (cyan) or 
MyD88-/- (yellow) BMDMs. GO numbers for significantly enriched BP are indicated on 
the x-axis. (E-F) Protein networks of significant master regulator proteins. Green arrows 
indicate positive regulation from one protein to another. Black arrows indicate unknown 
effect of one protein on another. Proteins in gray boxes represent intermediates and red 
boxes indicate transcription factors. (E) Protein network of MyD88 (blue box) and 
downstream intermediates. (F) Protein network of MyD88-privative master regulators 
(yellow boxes) that significantly enriched to chemotaxis-related BP. 
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MyD88-privative master regulators are involved in multiple chemotactic biological 
processes not enriched in WT BMDMs. 
We also observed significant overlap between the chemotactic biological processes 
enriched in MyD88-dependent and MyD88-privative master regulators. However, MyD88-
privative master regulators significantly enriched to multiple biological processes involved 
in chemotaxis that were not enriched in MyD88-dependent master regulators (Figure 4B 
and 4D), suggesting that the lack of MyD88 signaling allows for increased up-regulation 
of processes to facilitate cell migration into the tissues. The MyD88-privative master 
regulators involved in these chemotactic processes also enriched to inflammatory 
processes (Figure 4B and 4D), suggesting that Bb may trigger other signaling cascades 
which induce inflammation more skewed to cell recruitment and localization. We then 
generated a network of two MyD88-privative master regulators that were up-regulated 
and significantly enriched to multiple chemotactic biological processes (Figure 4F). 
Interestingly, Cxcl2 was differentially expressed in the absence of MyD88 and also 
mapped as a master regulator in the network. Most importantly, both networks shown in 
Figure 4E and 4F provide potential targets for mutagenesis to test if they contribute to 
inflammation in humans.   
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CHAPTER 6: DISCUSSION 
 
Lyme disease affects approximately 25,000 people in the United States each year, with 
an additional 10,000 unconfirmed but probable cases (Adrion, Aucott et al. 2015, CDC 
2016). The spectrum of clinical manifestations seen in patients varies between 
asymptomatic, mild and more severe disease. Patients with severe LD can present with 
varying degrees of carditis, meningitis, optic neuritis and increased intracranial pressure 
(Steere and Glickstein 2004, Radolf, Caimano et al. 2012, CDC 2016, Steere, Strle et al. 
2016). It is also well established that some patients develop a wide spectrum of poorly 
understood post LD treatment inflammatory signs and symptoms (CDC 2016), as well as 
post-treatment arthritis. Thus, it is essential to gain a complete understanding for how the 
human immune system responds to Bb, facilitates clearance of the spirochete and 
contributes to the inflammatory clinical manifestation of the disease. Previous studies by 
our group have emphasized that uptake and degradation of Bb by phagocytic cells, 
including monocytes and macrophages, are critical in eliciting the inflammatory response 
to the bacterium (Moore, Cruz et al. 2007, Salazar, Duhnam-Ems et al. 2009, Cervantes, 
Dunham-Ems et al. 2011, Cervantes, La Vake et al. 2013, Cervantes, Hawley et al. 2014). 
The findings from these studies, as well as others (Shin, Isberg et al. 2008), show that 
the adaptor protein MyD88 plays a critical role in bacterial uptake and phagosomal 
signaling. in macrophages. In the current study we provide further evidence that the 
macrophage is a key driver of inflammation, even in the absence of MyD88. We also 
showed that while MyD88 has a significant impact on spirochetal uptake, phagosome 
maturation and bacteria degradation are not affected. Of particular novelty, phagosomal 
signaling cascades induced by Bb ligands in macrophages trigger a number of 
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inflammatory and chemotactic processes. Inflammatory processes are mediated by 
different regulatory proteins depending on whether MyD88 is present or absent, but 
similar processes are upregulated in both genotypes.  Induction of several chemotactic 
processes occurs independently of MyD88. Moreover, inflammatory and chemotactic 
signals in macrophages can also be emitted from within the phagosome, independently 
of MyD88, through interaction with a yet to be characterized receptor. In depth analysis 
of these signaling cascades allowed us to identify unique master regulators and 
transcription factors which need to be further explored to understand their potential role 
affecting the wide diversity of the clinical manifestations seen in human LD. In the current 
study we provide further evidence that the macrophage is a key driver of inflammation, 
even in the absence of MyD88. We also showed that while MyD88 has a significant impact 
on spirochetal uptake, phagosome maturation and bacteria degradation are not affected. 
These phenotypic changes are driven by the signaling cascades induced by MyD88 as a 
result of bacterial ligands engaging TLR receptors in the phagosome, triggering 
phagosomal signaling. 
 
The importance of MyD88 signaling in tissues to facilitate Bb clearance is a concept that 
has been well-studied, but the mechanisms that account for this effect have not been 
defined. Our results demonstrate that MyD88 signaling in Bb-infected mice affects 
spirochete clearance from multiple tissues. In bladder, skin, ear, and joint tissue the lack 
of MyD88 results in Bb burdens that remain elevated even 56 DPI. This finding is 
consistent with results from several previously recognized (Bolz, Sundsbak et al. 2004, 
Liu, Montgomery et al. 2004, Behera, Hildebrand et al. 2006). Liu et al demonstrated. 
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demonstrated increased bacterial burdens in MyD88-/- mouse bladders at 14 and 45 DPI, 
as well as blood culture positivity at 45 DPI (Liu, Montgomery et al. 2004). Bolz et al. 
showed increased spirochete burdens in MyD88-/- mice 2 weeks and 4 weeks post 
infection in heart, ear and ankle tissue (Bolz, Sundsbak et al. 2004). Behera et al. 
illustrated increased bacterial burdens in MyD88-/- mice 3 weeks post infection in joint, 
muscle and kidney tissue (Behera, Hildebrand et al. 2006). Overall these prior studies are 
comparable to our results shown in Figure 1, demonstrating that MyD88 signaling in Bb-
infected mice affects spirochete clearance from multiple tissues. In the current study we 
quantified Bb burdens in multiple target tissues at early (14 DPI), intermediate (28 DPI) 
and late (56 DPI) time points post-infection to create a more complete depiction of 
bacterial burden kinetics and how they are affected by the presence of MyD88. In bladder, 
skin, ear, and joint tissue the lack of MyD88 resulted in high Bb burdens, even 56 DPI. It 
should be noted that in contrast to prior work (Bolz, Sundsbak et al. 2004, Liu, 
Montgomery et al. 2004, Behera, Hildebrand et al. 2006), we did not observe significant 
differences in spirochete burdens at 14 DPI. Of particular importance, our findings 
suggest that MyD88 signaling enhances but is not required for bacterial control in heart 
tissue, since there was a reduction in Bb burdens in MyD88-/- mouse hearts 56 DPI. No 
change in the overall health of the mice was observed despite the high Bb burdens in 
MyD88-/- mice, indicating that while the mouse model is extremely useful for examining 
infiltrate at the cellular level, the effect of higher burdens on severity of clinical 
manifestations is difficult to determine. Whether MyD88 is required for Bb clearance in 
human tissues, and how it impacts this process in the context of LD is not known. 
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It is well accepted that infection with Bb triggers an inflammatory response, the 
robustness of which dictates the severity of human LD. Tissue-specific differences in 
inflammation in the mouse model of infection have been reported in prior studies (Bolz, 
Sundsbak et al. 2004, Behera, Hildebrand et al. 2006), but the characterization of the 
immune cell infiltrate occurring in the absence of MyD88 in those studies was very 
general. In this study we characterized the types of immune cells observed in Bb-infected 
tissue infiltrate, focusing on macrophages because of their role in early recognition and 
clearance. Interestingly, the heart tissue in MyD88-/- mice showed significantly more 
inflammation, with higher macrophage infiltrate 28 DPI. The robust macrophage 
recruitment to the heart illustrates the important role these cells have in clearing 
spirochetes. Montgomery et al.(Montgomery, Booth et al. 2007) showed that inhibiting 
chemotaxis of macrophages to the heart resulted in increased Bb burdens, but our study 
findings show increased Bb burdens in MyD88-/- hearts 28 DPI despite robust 
macrophage recruitment. This phenotype is rescued somewhat at 56 DPI when Bb 
burdens are reduced in MyD88-/- hearts. Taken together, findings from our in vivo heart 
studies suggest three major points. First, immune cell recruitment is not regulated by 
MyD88, since macrophages readily appear in infected heart tissue despite the lack of 
MyD88 signaling and chemokine production is significantly upregulated. Second, MyD88 
signaling in macrophages is required for them to maintain the ability to effectively control 
Bb burdens in heart tissue, whether or not they are successfully able to migrate to sites 
of infection. Third, reduced or delayed spirochete clearance from heart tissue due to the 
absence of MyD88 signaling results in more phagocytic cells being recruited in attempt 
to control the infection, as indicated by the increased infiltrate seen in MyD88-/- mouse 
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hearts. These phagocytic cells, despite their diminished ability to capture spirochetes, 
eventually begin to control the bacterial loads. This could potentially be due to the 
availability of antibodies to opsonize spirochetes for uptake via Fc receptors (Liu, 
Montgomery et al. 2004, Belperron, Liu et al. 2014). However, macrophages are not the 
only cell driving spirochete clearance in vivo. Infected MyD88-/- mouse hearts also 
showed significant neutrophil infiltration 28 DPI, greater than WT mice, suggesting that, 
similar to joints, neutrophils also play a role in chemokine production and Bb clearance in 
the heart (Ritzman, Hughes-Hanks et al. 2010). Whether MyD88 signaling affects the 
ability of neutrophils to efficiently capture spirochetes is not known. 
 
Unlike heart tissue, we did not observe increased inflammation in MyD88-/- joint tissue, 
despite seeing significant chemokine upregulation 28 DPI. This is in contrast to prior 
studies that showed greater neutrophil infiltrate in the joints of Bb-infected MyD88-/- mice 
(Bolz, Sundsbak et al. 2004). The lack of increased macrophage or neutrophil infiltrate in 
joints during Bb infection suggests that another cell is driving bacterial clearance in this 
tissue. This alternative response is not as effective at spirochete clearance because 
MyD88-/- mouse Bb burdens persist in tibiotarsal joints 56 DPI, providing further support 
that MyD88 also affects the ability of immune cells besides the macrophage to capture 
spirochetes. Despite high Bb burdens the inflammation in joint tissue was very mild, 
indicating that the phenomenon of recruiting more inflammatory in attempt to control the 
infection, as seen in heart tissue, is not observed in joint tissue. However, macrophages 
and neutrophils have been identified in synovial fluid and joint space of patients with Lyme 
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arthritis (Steere and Glickstein 2004), indicating that these cells have a much stronger 
role in the human inflammatory response in joints rather than heart.  
 
An important step in this process is degradation of the bacteria to expose TLR ligands, 
which occurs only when the phagosome has matured and acidified. The requirement of 
MyD88 in this process is questionable; our results indicate that in the context of Bb 
infection, MyD88 is not required for phagosome maturation, evidenced by the recruitment 
of LAMP-1 to Bb-containing phagosomes in MyD88-/- BMDMs. Blander et al. published 
that MyD88-/- BMDMs infected with S. aureus or E. coli did not colocalize with either 
Lysotracker or LAMP-1 to the same degree as WT BMDMs (Blander and Medzhitov 
2004). One possible explanation for this is that the recruitment of LAMP-1 is delayed in 
MyD88-/- BMDMs, given that Blander et al. measured phagosome maturation 1 hour after 
stimulation while our analysis was done 6 hours after stimulation. This explanation is 
supported by Yates et al. who showed slightly delayed acidification in MyD88-/- BMDMs 
stimulated with TLR2 or TLR4 ligands for 40 minutes (Yates and Russell 2005). The 
fragility of the Bb membranes also suggests that perhaps less acidification of the 
phagosome is needed to expose Bb PAMPs. Importantly, additional studies in human 
macrophages, which readily phagocytose Bb (Hawley, Cruz et al. 2017), will reveal 
whether possible variations in degradation affect recognition of Bb by the human immune 
system, and thus affect the inflammatory response.  
 
Murine macrophages lacking MyD88 show a phagocytic defect when stimulated with Bb 
ex vivo compared to WT macrophages. Our results reveal that this phagocytic defect is 
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not dependent on length of stimulation (i.e. time dependent) and is only slightly rescued 
by increasing the MOI. Thus, in the absence of MyD88, macrophages are still capable of 
binding and uptake of the LD spirochete, but MyD88 signaling enhances the efficiency of 
Bb uptake by macrophages (Figure 1). This phenotype has been previously 
demonstrated with other bacteria (Edelson and Unanue 2002, Blander and Medzhitov 
2004, Ip, Sokolovska et al. 2010, Shen, Kawamura et al. 2010). The direct correlation 
between MyD88 signaling and enhanced bacterial uptake has yet to be identified, but 
several advances have been made in determining proteins that link these cellular 
processes. Addition of TLR3 ligands to Bb stimulation of MyD88-/- BMDMs significantly 
rescues uptake (Shin, Miller et al. 2009), suggesting that in the absence of MyD88 TRIF 
signaling can activate pathways that result in similar actin rearrangement in the cell. 
Additional studies indicating that TLR2 can utilize TRIF have also been completed, but 
this interaction only appears to contribute to the inflammatory response rather than 
spirochete uptake (Salazar, Duhnam-Ems et al. 2009, Petnicki-Ocwieja, Chung et al. 
2013). More recently, work by Killpack et al. (2017) showed an important role for spleen 
tyrosine kinase (Syk) in phagocytosis of Bb via integrin binding. The Syk gene (Syk) is 
significantly upregulated in an MyD88-dependent manner, suggesting that MyD88 drives 
over-expression of Syk to increase phosphorylation and activation of proteins involved in 
generating actin branches. In our GO analysis Syk was not one of the 164 MyD88-
dependent genes that enriched to uptake biological processes, and the transcription 
factor Zic1, which has binding sites in the promoter regions of a significant number of 
these genes, is not predicted to bind in the promoter region of Syk. Zic1 was of particular 
interest to us because it appeared downstream of MyD88 in our network analysis and is 
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controlled by the intermediate protein ApoE. Mice lacking ApoE have increased bacterial 
burdens when infected with Bb (Toledo, Monzon et al. 2015), suggesting that ApoE 
signaling plays a role in cell remodeling processes necessary to enhance uptake. In 
addition, a link between Bb phagocytosis and cholesterol has been postulated by Hawley 
et al. (Hawley, Martin-Ruiz et al. 2013) who showed that CR3, a known phagocytic 
receptor for Bb, is recruited to lipid rafts with the co-receptor CD14. Thus, it is possible 
that MyD88 upregulates ApoE to enhance lipid rafts on the macrophage membrane, 
which can potentiate signaling to enhance uptake and provide scaffolding for proteins 
involved in actin remodeling.  
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Figure 1: Model of phagocytic processes associated with Bb uptake. Initial 
interaction of Bb with surface integrins results in recruitment of kinases to 
phosphorylate the plasma membrane and activate guanine exchange factors (GEFs). 
GEFs activate Rho GTPases to induce actin polymerization and filopodia protrusions 
which form the phagocytic cup. Rab proteins facilitate coiling of Bb into a phagosome 
where degradation releases bacterial ligands for recognition by endosomal TLRs. 
MyD88 signaling downstream of these TLRs potentially activates transcription factors 
that control genes which affect coiling pseudopod protrusion for more efficient 
spirochete uptake. 
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Another important question raised by the RNA sequencing data is the non-canonical 
sources of inflammation seen in MyD88-/- mice. Our model traditionally predicts that due 
to the lack of TLR signaling Bb ligands cannot be recognized in the phagosome to trigger 
inflammatory signals. However, chemokine production by macrophages suggests that 
there is possibly another receptor recruited the phagosome that initiates chemokine 
production. The Bb ligand for this receptor is exposed in the phagosome, as indicated by 
Figure 7. Another mechanism for triggering chemokine production may be that the TLR 
receptors are utilizing another adaptor protein to transmit signals out of the phagosome, 
as postulated by Petnicki-Ocwieja et al. (Petnicki-Ocwieja, Chung et al. 2013). The 
production of chemokines facilitates recruitment of cells to spirochetes infected tissues, 
but the increased cell recruitment in MyD88-/- mice, coupled with higher Bb burdens 
suggests that the infiltrating immune cells are not efficient at clearing spirochetes. To 
compensate for their lack of efficiency at uptake, more cells are recruited. This 
progression of events may not be true for joint tissue compared to heart tissue, since our 
results show that the chemokine responses are different in both tissues and different cell 
types are recruited to each tissue. Network analysis of DEGs from macrophages identified 
multiple master regulators that could be controlling production of these chemokines, but 
further work needs to be done to determine if these master regulators are in fact active in 
macrophages containing Bb. Additional studies to test whether acidification of the 
phagosome is required for Bb-induced chemokine production will also give insight into 
which ligand-receptor interaction induces this response. 
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In summary, our results emphasize that the macrophage has a very important role in both 
recognition and clearance of Bb and is at the epicenter of the immunologic response to 
spirochete infection, particularly in relation to Lyme carditis. We also identified multiple 
factors that play a role in the efficiency of these processes. One crucial step is the 
recruitment of cells to the tissue via production of chemokines, which does not require 
MyD88 signaling but does require uptake of spirochetes. The necessity of uptake for 
significant chemokine upregulation is supported by our data showing that MyD88 is not 
required for phagosome maturation, a key step in exposing Bb ligands for recognition. 
Another aspect of this response requires MyD88 signaling cascades to elicit an 
inflammatory response that results in cell remodeling to enhance phagocytosis, as 
indicated by our ex vivo data. This allows macrophages to efficiently take up and clear 
spirochetes. The robustness of both the macrophage response and MyD88 signaling in 
human cells could also play a significant role in symptom severity and manifestation 
spectrum seen in patients with LD, affecting whether increased recruitment and activity 
of these cells plays a role in the long-term inflammation that develops in some individuals. 
Once translated in to human cells, these studies identify potential targets for treatment of 
Lyme disease in humans and increased understanding of the clinical spectrum of Lyme 
disease.  
 
 
 
  
 88 
REFERENCES 
Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi and S. 
Akira (1998). "Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated 
function." Immunity 9(1): 143-150. 
Adrion, E. R., J. Aucott, K. W. Lemke and J. P. Weiner (2015). "Health care costs, utilization and 
patterns of care following Lyme disease." PLoS One 10(2): e0116767. 
Ahuja, S. K. and P. M. Murphy (1996). "The CXC chemokines growth-regulated oncogene (GRO) 
alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived 
neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human 
interleukin-8 receptor." J Biol Chem 271(34): 20545-20550. 
Anders, S. and W. Huber (2010). "Differential expression analysis for sequence count data." 
Genome Biol 11(10): R106. 
Armstrong, A. L., S. W. Barthold, D. H. Persing and D. S. Beck (1992). "Carditis in Lyme disease 
susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi." Am J Trop 
Med Hyg 47(2): 249-258. 
Barthold, S. W., D. S. Beck, G. M. Hansen, G. A. Terwilliger and K. D. Moody (1990). "Lyme 
borreliosis in selected strains and ages of laboratory mice." J Infect Dis 162(1): 133-138. 
Barthold, S. W., D. H. Persing, A. L. Armstrong and R. A. Peeples (1991). "Kinetics of Borrelia 
burgdorferi dissemination and evolution of disease after intradermal inoculation of mice." Am J 
Pathol 139(2): 263-273. 
Behera, A. K., E. Hildebrand, R. T. Bronson, G. Perides, S. Uematsu, S. Akira and L. T. Hu (2006). 
"MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in 
interleukin-18-independent mice infected with Borrelia burgdorferi." Infect Immun 74(3): 1462-
1470. 
Behera, A. K., E. Hildebrand, S. Uematsu, S. Akira, J. Coburn and L. T. Hu (2006). "Identification 
of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix 
metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1." J 
Immunol 177(1): 657-664. 
Belperron, A. A., N. Liu, C. J. Booth and L. K. Bockenstedt (2014). "Dual role for Fcgamma 
receptors in host defense and disease in Borrelia burgdorferi-infected mice." Front Cell Infect 
Microbiol 4: 75. 
Benhnia, M. R., D. Wroblewski, M. N. Akhtar, R. A. Patel, W. Lavezzi, S. C. Gangloff, S. M. Goyert, 
M. J. Caimano, J. D. Radolf and T. J. Sellati (2005). "Signaling through CD14 attenuates the 
inflammatory response to Borrelia burgdorferi, the agent of Lyme disease." J Immunol 174(3): 
1539-1548. 
Blander, J. M. (2007). "Coupling Toll-like receptor signaling with phagocytosis: potentiation of 
antigen presentation." Trends Immunol 28(1): 19-25. 
Blander, J. M. and R. Medzhitov (2004). "Regulation of phagosome maturation by signals from 
toll-like receptors." Science 304(5673): 1014-1018. 
 89 
Bockenstedt, J. J. W. a. L. K. (2010). Host Response. Borrelia: Molecular Biology, Host Interaction 
and Pathogenesis. D. S. S. a. J. D. Radolf. Norfolk UK, Caister Academic Press: 413-441. 
Bolz, D. D., R. S. Sundsbak, Y. Ma, S. Akira, C. J. Kirschning, J. F. Zachary, J. H. Weis and J. J. 
Weis (2004). "MyD88 plays a unique role in host defense but not arthritis development in Lyme 
disease." J Immunol 173(3): 2003-2010. 
Brandt, M. E., B. S. Riley, J. D. Radolf and M. V. Norgard (1990). "Immunogenic integral 
membrane proteins of Borrelia burgdorferi are lipoproteins." Infect Immun 58(4): 983-991. 
CDC. (2016). "Lyme Disease Incidence Rates by State 2004-2015." from 
http://www.cdc.gov/lyme/stats/chartstables/incidencebystate.html. 
CDC. (2016). "Post Treatment Lyme Disease Syndrome." from 
http://www.cdc.gov/lyme/postlds/index.html. 
CDC. (2016). "Signs and Symptoms of Untreated Lyme Disease." from 
http://www.cdc.gov/lyme/signs_symptoms/index.html. 
Cervantes, J. L., S. M. Dunham-Ems, C. J. La Vake, M. M. Petzke, B. Sahay, T. J. Sellati, J. D. 
Radolf and J. C. Salazar (2011). "Phagosomal signaling by Borrelia burgdorferi in human 
monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated 
induction of IFN-beta." Proc Natl Acad Sci U S A 108(9): 3683-3688. 
Cervantes, J. L., K. L. Hawley, S. J. Benjamin, B. Weinerman, S. M. Luu and J. C. Salazar (2014). 
"Phagosomal TLR signaling upon Borrelia burgdorferi infection." Front Cell Infect Microbiol 4: 55. 
Cervantes, J. L., C. J. La Vake, B. Weinerman, S. Luu, C. O'Connell, P. H. Verardi and J. C. 
Salazar (2013). "Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the 
phagosome of human monocytes." J Leukoc Biol 94(6): 1231-1241. 
Coburn, J., L. Magoun, S. C. Bodary and J. M. Leong (1998). "Integrins alpha(v)beta3 and 
alpha5beta1 mediate attachment of lyme disease spirochetes to human cells." Infect Immun 
66(5): 1946-1952. 
Curtis, M. W., B. L. Hahn, K. Zhang, C. Li, R. T. Robinson and J. Coburn (2018). "Characterization 
of Stress and Innate Immunity Resistance of Wild-Type and Deltap66 Borrelia burgdorferi." Infect 
Immun 86(2). 
de Souza, M. S., A. L. Smith, D. S. Beck, L. J. Kim, G. M. Hansen, Jr. and S. W. Barthold (1993). 
"Variant responses of mice to Borrelia burgdorferi depending on the site of intradermal 
inoculation." Infect Immun 61(10): 4493-4497. 
Devreotes, P. and A. R. Horwitz (2015). "Signaling networks that regulate cell migration." Cold 
Spring Harb Perspect Biol 7(8): a005959. 
Dunham-Ems, S. M., M. J. Caimano, C. H. Eggers and J. D. Radolf (2012). "Borrelia burgdorferi 
requires the alternative sigma factor RpoS for dissemination within the vector during tick-to-
mammal transmission." PLoS Pathog 8(2): e1002532. 
 90 
Dunham-Ems, S. M., M. J. Caimano, U. Pal, C. W. Wolgemuth, C. H. Eggers, A. Balic and J. D. 
Radolf (2009). "Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi 
within ticks." J Clin Invest 119(12): 3652-3665. 
Edelson, B. T. and E. R. Unanue (2002). "MyD88-dependent but Toll-like receptor 2-independent 
innate immunity to Listeria: no role for either in macrophage listericidal activity." J Immunol 169(7): 
3869-3875. 
Elsner, R. A., C. J. Hastey and N. Baumgarth (2015). "CD4+ T cells promote antibody production 
but not sustained affinity maturation during Borrelia burgdorferi infection." Infect Immun 83(1): 48-
56. 
Fortune, D. E., Y. P. Lin, R. K. Deka, A. M. Groshong, B. P. Moore, K. E. Hagman, J. M. Leong, 
D. R. Tomchick and J. S. Blevins (2014). "Identification of lysine residues in the Borrelia 
burgdorferi DbpA adhesin required for murine infection." Infect Immun 82(8): 3186-3198. 
Fraser, C. M., S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton, R. Lathigra, O. White, K. A. 
Ketchum, R. Dodson, E. K. Hickey, M. Gwinn, B. Dougherty, J. F. Tomb, R. D. Fleischmann, D. 
Richardson, J. Peterson, A. R. Kerlavage, J. Quackenbush, S. Salzberg, M. Hanson, R. van Vugt, 
N. Palmer, M. D. Adams, J. Gocayne, J. Weidman, T. Utterback, L. Watthey, L. McDonald, P. 
Artiach, C. Bowman, S. Garland, C. Fuji, M. D. Cotton, K. Horst, K. Roberts, B. Hatch, H. O. Smith 
and J. C. Venter (1997). "Genomic sequence of a Lyme disease spirochaete, Borrelia 
burgdorferi." Nature 390(6660): 580-586. 
Gebbia, J. A., J. L. Coleman and J. L. Benach (2001). "Borrelia spirochetes upregulate release 
and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in 
human cells." Infect Immun 69(1): 456-462. 
Guo, B. P., E. L. Brown, D. W. Dorward, L. C. Rosenberg and M. Hook (1998). "Decorin-binding 
adhesins from Borrelia burgdorferi." Mol Microbiol 30(4): 711-723. 
Hartmann, K., C. Corvey, C. Skerka, M. Kirschfink, M. Karas, V. Brade, J. C. Miller, B. Stevenson, 
R. Wallich, P. F. Zipfel and P. Kraiczy (2006). "Functional characterization of BbCRASP-2, a 
distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators 
factor H and FHL-1." Mol Microbiol 61(5): 1220-1236. 
Hastey, C. J., J. Ochoa, K. J. Olsen, S. W. Barthold and N. Baumgarth (2014). "MyD88- and TRIF-
independent induction of type I interferon drives naive B cell accumulation but not loss of lymph 
node architecture in Lyme disease." Infect Immun 82(4): 1548-1558. 
Hawley, K., N. Navasa, C. M. Olson, Jr., T. C. Bates, R. Garg, M. N. Hedrick, D. Conze, M. Rincon 
and J. Anguita (2012). "Macrophage p38 mitogen-activated protein kinase activity regulates 
invariant natural killer T-cell responses during Borrelia burgdorferi infection." J Infect Dis 206(2): 
283-291. 
Hawley, K. L., A. R. Cruz, S. J. Benjamin, C. J. La Vake, J. L. Cervantes, M. LeDoyt, L. G. 
Ramirez, D. Mandich, M. Fiel-Gan, M. J. Caimano, J. D. Radolf and J. C. Salazar (2017). 
"IFNgamma Enhances CD64-Potentiated Phagocytosis of Treponema pallidum Opsonized with 
Human Syphilitic Serum by Human Macrophages." Front Immunol 8: 1227. 
 91 
Hawley, K. L., I. Martin-Ruiz, J. M. Iglesias-Pedraz, B. Berwin and J. Anguita (2013). "CD14 
targets complement receptor 3 to lipid rafts during phagocytosis of Borrelia burgdorferi." Int J Biol 
Sci 9(8): 803-810. 
Hawley, K. L., C. M. Olson, Jr., J. M. Iglesias-Pedraz, N. Navasa, J. L. Cervantes, M. J. Caimano, 
H. Izadi, R. R. Ingalls, U. Pal, J. C. Salazar, J. D. Radolf and J. Anguita (2012). "CD14 cooperates 
with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi." 
Proc Natl Acad Sci U S A 109(4): 1228-1232. 
Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner 
and S. Bauer (2004). "Species-specific recognition of single-stranded RNA via toll-like receptor 7 
and 8." Science 303(5663): 1526-1529. 
Hellwage, J., T. Meri, T. Heikkila, A. Alitalo, J. Panelius, P. Lahdenne, I. J. Seppala and S. Meri 
(2001). "The complement regulator factor H binds to the surface protein OspE of Borrelia 
burgdorferi." J Biol Chem 276(11): 8427-8435. 
Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten and J. J. 
Weis (1999). "Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is 
mediated by toll-like receptor 2." J Immunol 163(5): 2382-2386. 
Hoffmann, A. K., X. Naj and S. Linder (2014). "Daam1 is a regulator of filopodia formation and 
phagocytic uptake of Borrelia burgdorferi by primary human macrophages." FASEB J 28(7): 3075-
3089. 
Hyde, J. A., E. H. Weening, M. Chang, J. P. Trzeciakowski, M. Hook, J. D. Cirillo and J. T. Skare 
(2011). "Bioluminescent imaging of Borrelia burgdorferi in vivo demonstrates that the fibronectin-
binding protein BBK32 is required for optimal infectivity." Mol Microbiol 82(1): 99-113. 
Ip, W. K., A. Sokolovska, G. M. Charriere, L. Boyer, S. Dejardin, M. P. Cappillino, L. M. Yantosca, 
K. Takahashi, K. J. Moore, A. Lacy-Hulbert and L. M. Stuart (2010). "Phagocytosis and 
phagosome acidification are required for pathogen processing and MyD88-dependent responses 
to Staphylococcus aureus." J Immunol 184(12): 7071-7081. 
Keller, A. D. and T. Maniatis (1991). "Identification and characterization of a novel repressor of 
beta-interferon gene expression." Genes Dev 5(5): 868-879. 
Kenedy, M. R., T. R. Lenhart and D. R. Akins (2012). "The role of Borrelia burgdorferi outer 
surface proteins." FEMS Immunol Med Microbiol 66(1): 1-19. 
Kim, D., G. Pertea, C. Trapnell, H. Pimentel, R. Kelley and S. L. Salzberg (2013). "TopHat2: 
accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions." 
Genome Biol 14(4): R36. 
Kraiczy, P., J. Hellwage, C. Skerka, H. Becker, M. Kirschfink, M. M. Simon, V. Brade, P. F. Zipfel 
and R. Wallich (2004). "Complement resistance of Borrelia burgdorferi correlates with the 
expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with 
human factor H and FHL-1 and is unrelated to Erp proteins." J Biol Chem 279(4): 2421-2429. 
Krull, M., S. Pistor, N. Voss, A. Kel, I. Reuter, D. Kronenberg, H. Michael, K. Schwarzer, A. 
Potapov, C. Choi, O. Kel-Margoulis and E. Wingender (2006). "TRANSPATH: an information 
 92 
resource for storing and visualizing signaling pathways and their pathological aberrations." 
Nucleic Acids Res 34(Database issue): D546-551. 
Kurtenbach, K., K. Hanincova, J. I. Tsao, G. Margos, D. Fish and N. H. Ogden (2006). 
"Fundamental processes in the evolutionary ecology of Lyme borreliosis." Nat Rev Microbiol 4(9): 
660-669. 
Lasky, C. E., R. M. Olson and C. R. Brown (2015). "Macrophage Polarization during Murine Lyme 
Borreliosis." Infect Immun 83(7): 2627-2635. 
Levin, R., S. Grinstein and J. Canton (2016). "The life cycle of phagosomes: formation, 
maturation, and resolution." Immunol Rev 273(1): 156-179. 
Lister, R., B. D. Gregory and J. R. Ecker (2009). "Next is now: new technologies for sequencing 
of genomes, transcriptomes, and beyond." Curr Opin Plant Biol 12(2): 107-118. 
Liu, N., R. R. Montgomery, S. W. Barthold and L. K. Bockenstedt (2004). "Myeloid differentiation 
antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia 
burgdorferi-infected mice." Infect Immun 72(6): 3195-3203. 
Mantovani, A., A. Sica, S. Sozzani, P. Allavena, A. Vecchi and M. Locati (2004). "The chemokine 
system in diverse forms of macrophage activation and polarization." Trends Immunol 25(12): 677-
686. 
Matys, V., O. V. Kel-Margoulis, E. Fricke, I. Liebich, S. Land, A. Barre-Dirrie, I. Reuter, D. 
Chekmenev, M. Krull, K. Hornischer, N. Voss, P. Stegmaier, B. Lewicki-Potapov, H. Saxel, A. E. 
Kel and E. Wingender (2006). "TRANSFAC and its module TRANSCompel: transcriptional gene 
regulation in eukaryotes." Nucleic Acids Res 34(Database issue): D108-110. 
Mead, P. S. (2015). "Epidemiology of Lyme disease." Infect Dis Clin North Am 29(2): 187-210. 
Montgomery, R. R., C. J. Booth, X. Wang, V. A. Blaho, S. E. Malawista and C. R. Brown (2007). 
"Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis." Infect Immun 
75(2): 613-620. 
Moore, M. W., A. R. Cruz, C. J. LaVake, A. L. Marzo, C. H. Eggers, J. C. Salazar and J. D. Radolf 
(2007). "Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune 
activation and induces gamma interferon production." Infect Immun 75(4): 2046-2062. 
Muehlenbachs, A., B. C. Bollweg, T. J. Schulz, J. D. Forrester, M. DeLeon Carnes, C. Molins, G. 
S. Ray, P. M. Cummings, J. M. Ritter, D. M. Blau, T. A. Andrew, M. Prial, D. L. Ng, J. A. Prahlow, 
J. H. Sanders, W. J. Shieh, C. D. Paddock, M. E. Schriefer, P. Mead and S. R. Zaki (2016). 
"Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated 
with Lyme Carditis." Am J Pathol 186(5): 1195-1205. 
Naj, X., A. K. Hoffmann, M. Himmel and S. Linder (2013). "The formins FMNL1 and mDia1 
regulate coiling phagocytosis of Borrelia burgdorferi by primary human macrophages." Infect 
Immun 81(5): 1683-1695. 
 93 
Naj, X. and S. Linder (2015). "ER-Coordinated Activities of Rab22a and Rab5a Drive Phagosomal 
Compaction and Intracellular Processing of Borrelia burgdorferi by Macrophages." Cell Rep 
12(11): 1816-1830. 
Naj, X. and S. Linder (2017). "Actin-Dependent Regulation of Borrelia burgdorferi Phagocytosis 
by Macrophages." Curr Top Microbiol Immunol 399: 133-154. 
Niedergang, F. and S. Grinstein (2018). "How to build a phagosome: new concepts for an old 
process." Curr Opin Cell Biol 50: 57-63. 
Norgard, M. V., L. L. Arndt, D. R. Akins, L. L. Curetty, D. A. Harrich and J. D. Radolf (1996). 
"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins 
and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but 
involves the transcriptional activator NF-kappa B." Infect Immun 64(9): 3845-3852. 
Oosting, M., A. Berende, P. Sturm, H. J. Ter Hofstede, D. J. de Jong, T. D. Kanneganti, J. W. van 
der Meer, B. J. Kullberg, M. G. Netea and L. A. Joosten (2010). "Recognition of Borrelia 
burgdorferi by NOD2 is central for the induction of an inflammatory reaction." J Infect Dis 201(12): 
1849-1858. 
Oosting, M., F. L. van de Veerdonk, T. D. Kanneganti, P. Sturm, I. Verschueren, A. Berende, J. 
W. van der Meer, B. J. Kullberg, M. G. Netea and L. A. Joosten (2011). "Borrelia species induce 
inflammasome activation and IL-17 production through a caspase-1-dependent mechanism." Eur 
J Immunol 41(1): 172-181. 
Pal, U., A. M. de Silva, R. R. Montgomery, D. Fish, J. Anguita, J. F. Anderson, Y. Lobet and E. 
Fikrig (2000). "Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer 
surface protein A." J Clin Invest 106(4): 561-569. 
Pal, U., X. Li, T. Wang, R. R. Montgomery, N. Ramamoorthi, A. M. Desilva, F. Bao, X. Yang, M. 
Pypaert, D. Pradhan, F. S. Kantor, S. Telford, J. F. Anderson and E. Fikrig (2004). "TROSPA, an 
Ixodes scapularis receptor for Borrelia burgdorferi." Cell 119(4): 457-468. 
Pawlik, A., D. Kotrych, E. Paczkowska, D. Roginska, V. Dziedziejko, K. Safranow and B. 
Machalinski (2016). "Expression of allograft inflammatory factor-1 in peripheral blood monocytes 
and synovial membranes in patients with rheumatoid arthritis." Hum Immunol 77(1): 131-136. 
Petnicki-Ocwieja, T., E. Chung, D. I. Acosta, L. T. Ramos, O. S. Shin, S. Ghosh, L. Kobzik, X. Li 
and L. T. Hu (2013). "TRIF mediates Toll-like receptor 2-dependent inflammatory responses to 
Borrelia burgdorferi." Infect Immun 81(2): 402-410. 
Petzke, M. M., A. Brooks, M. A. Krupna, D. Mordue and I. Schwartz (2009). "Recognition of 
Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN 
response by human immune cells." J Immunol 183(8): 5279-5292. 
Radolf, J. D., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis and M. V. 
Norgard (1995). "Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic 
lipopeptides activate monocytes/macrophages." J Immunol 154(6): 2866-2877. 
 94 
Radolf, J. D., M. J. Caimano, B. Stevenson and L. T. Hu (2012). "Of ticks, mice and men: 
understanding the dual-host lifestyle of Lyme disease spirochaetes." Nat Rev Microbiol 10(2): 87-
99. 
Radolf, J. D., M. S. Goldberg, K. Bourell, S. I. Baker, J. D. Jones and M. V. Norgard (1995). 
"Characterization of outer membranes isolated from Borrelia burgdorferi, the Lyme disease 
spirochete." Infect Immun 63(6): 2154-2163. 
Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson and B. Beutler (1991). 
"Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis 
factor synthesis. Analysis using a CAT reporter construct." J Immunol 147(6): 1968-1974. 
Ribes, S., T. Regen, T. Meister, S. C. Tauber, S. Schutze, A. Mildner, M. Mack, U. K. Hanisch 
and R. Nau (2013). "Resistance of the brain to Escherichia coli K1 infection depends on MyD88 
signaling and the contribution of neutrophils and monocytes." Infect Immun 81(5): 1810-1819. 
Ristow, L. C., H. E. Miller, L. J. Padmore, R. Chettri, N. Salzman, M. J. Caimano, P. A. Rosa and 
J. Coburn (2012). "The beta(3)-integrin ligand of Borrelia burgdorferi is critical for infection of mice 
but not ticks." Mol Microbiol 85(6): 1105-1118. 
Ritzman, A. M., J. M. Hughes-Hanks, V. A. Blaho, L. E. Wax, W. J. Mitchell and C. R. Brown 
(2010). "The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment 
and is critical for development of experimental Lyme arthritis and carditis." Infect Immun 78(11): 
4593-4600. 
Russell, T. M., M. J. Delorey and B. J. Johnson (2013). "Borrelia burgdorferi BbHtrA degrades 
host ECM proteins and stimulates release of inflammatory cytokines in vitro." Mol Microbiol 90(2): 
241-251. 
Salazar, J. C., S. Duhnam-Ems, C. La Vake, A. R. Cruz, M. W. Moore, M. J. Caimano, L. Velez-
Climent, J. Shupe, W. Krueger and J. D. Radolf (2009). "Activation of human monocytes by live 
Borrelia burgdorferi generates TLR2-dependent and -independent responses which include 
induction of IFN-beta." PLoS Pathog 5(5): e1000444. 
Salazar, J. C., C. D. Pope, T. J. Sellati, H. M. Feder, Jr., T. G. Kiely, K. R. Dardick, R. L. Buckman, 
M. W. Moore, M. J. Caimano, J. G. Pope, P. J. Krause, J. D. Radolf and N. Lyme Disease (2003). 
"Coevolution of markers of innate and adaptive immunity in skin and peripheral blood of patients 
with erythema migrans." J Immunol 171(5): 2660-2670. 
Schenk, M., J. T. Belisle and R. L. Modlin (2009). "TLR2 looks at lipoproteins." Immunity 31(6): 
847-849. 
Schmittgen, T. D. and K. J. Livak (2008). "Analyzing real-time PCR data by the comparative C(T) 
method." Nat Protoc 3(6): 1101-1108. 
Schwan, T. G. (2003). "Temporal regulation of outer surface proteins of the Lyme-disease 
spirochaete Borrelia burgdorferi." Biochem Soc Trans 31(Pt 1): 108-112. 
Schwan, T. G. and J. Piesman (2000). "Temporal changes in outer surface proteins A and C of 
the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks 
and mice." J Clin Microbiol 38(1): 382-388. 
 95 
Sellati, T. J., D. A. Bouis, M. J. Caimano, J. A. Feulner, C. Ayers, E. Lien and J. D. Radolf (1999). 
"Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated 
by CD14 and correlates with surface exposure of spirochetal lipoproteins." J Immunol 163(4): 
2049-2056. 
Shannon, P., A. Markiel, O. Ozier, N. S. Baliga, J. T. Wang, D. Ramage, N. Amin, B. Schwikowski 
and T. Ideker (2003). "Cytoscape: a software environment for integrated models of biomolecular 
interaction networks." Genome Res 13(11): 2498-2504. 
Shen, Y., I. Kawamura, T. Nomura, K. Tsuchiya, H. Hara, S. R. Dewamitta, S. Sakai, H. Qu, S. 
Daim, T. Yamamoto and M. Mitsuyama (2010). "Toll-like receptor 2- and MyD88-dependent 
phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria 
monocytogenes by murine macrophages." Infect Immun 78(6): 2857-2867. 
Shin, J. J., K. Strle, L. J. Glickstein, A. D. Luster and A. C. Steere (2010). "Borrelia burgdorferi 
stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis." 
Arthritis Res Ther 12(5): R168. 
Shin, O. S., R. R. Isberg, S. Akira, S. Uematsu, A. K. Behera and L. T. Hu (2008). "Distinct roles 
for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine 
induction." Infect Immun 76(6): 2341-2351. 
Shin, O. S., L. S. Miller, R. L. Modlin, S. Akira, S. Uematsu and L. T. Hu (2009). "Downstream 
signals for MyD88-mediated phagocytosis of Borrelia burgdorferi can be initiated by TRIF and are 
dependent on PI3K." J Immunol 183(1): 491-498. 
Skare, J. T., T. A. Mirzabekov, E. S. Shang, D. R. Blanco, H. Erdjument-Bromage, J. Bunikis, S. 
Bergstrom, P. Tempst, B. L. Kagan, J. N. Miller and M. A. Lovett (1997). "The Oms66 (p66) protein 
is a Borrelia burgdorferi porin." Infect Immun 65(9): 3654-3661. 
Sokolovska, A., C. E. Becker, W. K. Ip, V. A. Rathinam, M. Brudner, N. Paquette, A. Tanne, S. K. 
Vanaja, K. J. Moore, K. A. Fitzgerald, A. Lacy-Hulbert and L. M. Stuart (2013). "Activation of 
caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control 
phagosome function." Nat Immunol 14(6): 543-553. 
Steere, A. C. and S. L. Arvikar (2015). "Editorial commentary: what constitutes appropriate 
treatment of post-Lyme disease symptoms and other pain and fatigue syndromes?" Clin Infect 
Dis 60(12): 1783-1785. 
Steere, A. C. and L. Glickstein (2004). "Elucidation of Lyme arthritis." Nat Rev Immunol 4(2): 143-
152. 
Steere, A. C., R. L. Grodzicki, J. E. Craft, M. Shrestha, A. N. Kornblatt and S. E. Malawista (1984). 
"Recovery of Lyme disease spirochetes from patients." Yale J Biol Med 57(4): 557-560. 
Steere, A. C., F. Strle, G. P. Wormser, L. T. Hu, J. A. Branda, J. W. Hovius, X. Li and P. S. Mead 
(2016). "Lyme borreliosis." Nat Rev Dis Primers 2: 16090. 
Takenawa, T. and S. Suetsugu (2007). "The WASP-WAVE protein network: connecting the 
membrane to the cytoskeleton." Nat Rev Mol Cell Biol 8(1): 37-48. 
 96 
Takeuchi, O., K. Hoshino and S. Akira (2000). "Cutting edge: TLR2-deficient and MyD88-deficient 
mice are highly susceptible to Staphylococcus aureus infection." J Immunol 165(10): 5392-5396. 
Tilly, K., J. G. Krum, A. Bestor, M. W. Jewett, D. Grimm, D. Bueschel, R. Byram, D. Dorward, M. 
J. Vanraden, P. Stewart and P. Rosa (2006). "Borrelia burgdorferi OspC protein required 
exclusively in a crucial early stage of mammalian infection." Infect Immun 74(6): 3554-3564. 
Toledo, A., J. D. Monzon, J. L. Coleman, J. C. Garcia-Monco and J. L. Benach (2015). 
"Hypercholesterolemia and ApoE deficiency result in severe infection with Lyme disease and 
relapsing-fever Borrelia." Proc Natl Acad Sci U S A 112(17): 5491-5496. 
Tunev, S. S., C. J. Hastey, E. Hodzic, S. Feng, S. W. Barthold and N. Baumgarth (2011). 
"Lymphoadenopathy during lyme borreliosis is caused by spirochete migration-induced specific 
B cell activation." PLoS Pathog 7(5): e1002066. 
Utans, U., R. J. Arceci, Y. Yamashita and M. E. Russell (1995). "Cloning and characterization of 
allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with 
chronic rejection." J Clin Invest 95(6): 2954-2962. 
Vera-Licona, P., E. Bonnet, E. Barillot and A. Zinovyev (2013). "OCSANA: optimal combinations 
of interventions from network analysis." Bioinformatics 29(12): 1571-1573. 
Vudattu, N. K., K. Strle, A. C. Steere and E. E. Drouin (2013). "Dysregulation of CD4+CD25(high) 
T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis." Arthritis Rheum 
65(6): 1643-1653. 
Westphal, A., W. Cheng, J. Yu, G. Grassl, M. Krautkramer, O. Holst, N. Foger and K. H. Lee 
(2017). "Lysosomal trafficking regulator Lyst links membrane trafficking to toll-like receptor-
mediated inflammatory responses." J Exp Med 214(1): 227-244. 
Whiteside, S. K., J. P. Snook, Y. Ma, F. L. Sonderegger, C. Fisher, C. Petersen, J. F. Zachary, J. 
L. Round, M. A. Williams and J. J. Weis (2018). "IL-10 Deficiency Reveals a Role for TLR2-
Dependent Bystander Activation of T Cells in Lyme Arthritis." J Immunol 200(4): 1457-1470. 
Williams, S. K., Z. P. Weiner and R. D. Gilmore (2018). "Human neuroglial cells internalize 
Borrelia burgdorferi by coiling phagocytosis mediated by Daam1." PLoS One 13(5): e0197413. 
Wooten, R. M., Y. Ma, R. A. Yoder, J. P. Brown, J. H. Weis, J. F. Zachary, C. J. Kirschning and 
J. J. Weis (2002). "Toll-like receptor 2 is required for innate, but not acquired, host defense to 
Borrelia burgdorferi." J Immunol 168(1): 348-355. 
Wormser, G. P. (2006). "Hematogenous dissemination in early Lyme disease." Wien Klin 
Wochenschr 118(21-22): 634-637. 
Yang, X. F., U. Pal, S. M. Alani, E. Fikrig and M. V. Norgard (2004). "Essential role for OspA/B in 
the life cycle of the Lyme disease spirochete." J Exp Med 199(5): 641-648. 
Yao, Z., M. K. Spriggs, J. M. Derry, L. Strockbine, L. S. Park, T. VandenBos, J. D. Zappone, S. L. 
Painter and R. J. Armitage (1997). "Molecular characterization of the human interleukin (IL)-17 
receptor." Cytokine 9(11): 794-800. 
 97 
Yates, R. M. and D. G. Russell (2005). "Phagosome maturation proceeds independently of 
stimulation of toll-like receptors 2 and 4." Immunity 23(4): 409-417. 
Zinovyev, A., E. Viara, L. Calzone and E. Barillot (2008). "BiNoM: a Cytoscape plugin for 
manipulating and analyzing biological networks." Bioinformatics 24(6): 876-877. 
 
 
 
